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Abstract 
Existing research suggests that a variety of environmental factors play an 
important role in cancer mortality. The association between some of these factors and 
cancer mortality was examined using data from the Charleston Heart Study, a thirty-five 
year prospective cohort. Baseline measurements for tobacco use, place of residence, 
occupation, education, water supply and physical activity were made in 1960/63 on 2,283 
participants. The vital status of the cohort was ascertained through 1994, and the 
underlying cause of death as determined by the nosologist was used to define cancer 
mortality. There were 294 cancer deaths identified over the 35-year period. Statistical 
analyses showed cigarette smoking and occupational history to be significant predictors 
for cancer mortality. In 1974/75 self reported information on pesticide and DDT use 
were collected and serum DDE levels were measured on 898 participants from the 
original cohort. There were 108 cancer deaths identified in the 20-year period between 
1974 and 1994. There was no difference in cancer mortality rates between those who 
reported pesticide use and those who did not. The mean serum level ofDDE for those 
dying of cancer was significantly less than the level observed in the remaining cohort 
(33.5 ppb vs. 37.2 ppb, p < 0.05). Analyses using proportional hazards regression models 
suggested no increase in the risk of cancer mortality associated with higher levels of 
DDE. The incidence of breast and prostate cancer was also evaluated using a nested case-
control design. There were 21 new breast cancers and 28 new prostate cancers identified 
.. 
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in the 20-year period. The mean serum level ofDDE for those with breast or prostate 
cancer was significantly less than the level of their matched controls (26.7 vs 35.1; 33.8 
vs 41.4 ppb, p<O.05). Results from conditional logistic regression models suggested no 
increase in either breast or prostate cancer risk associated with increasing levels ofDDE. 
In summary, there was no evidence to support an increased risk of breast cancer incidence 
for women, an increased risk of prostate cancer incidence for men, or an increased risk of 
cancer mortality for all subjects associated with DDE. 
I. Introduction 
Incidence rates for cancer have increased for all race and sex groups (Ries et aI., 
1994). For more than a decade, there has been general agreement that most cancer results 
from man-made and natural environmental exposures acting in concert with genetic and 
acquired characteristics (Perera, 1996). Exposure to environmental pollutants is nearly 
unavoidable. Some of the environmental factors suggested to be associated with cancer 
mortality and morbidity include tobacco use, pollution, diet, exposure to various man-
made chemicals including pesticides, viruses and socioeconomic factors, such as 
occupation, place of residence and educational attainment. It has been estimated that 
without these environmental factors, cancer incidence would be reduced by as much as 
80 to 90% (Higginson & Muir, 1976; Weinstein et al., 1995). 
Cigarette smoking has been purported to be the single most preventable cause of 
excess mortality in the U.S. It contributes as many as 25% to 40% of all cancer deaths 
(Ruddon, 1995). The effect of general pollutants in the air and water have been estimated 
to cause one to five percent of all cancer deaths (Doll & Peto, 1981). Occupational 
studies have played a sigrJficant role in identifying carcinogenic and possible 
carcinogenic agents such as metals, solvents, polymers and pesticides (IARC, 1987). For 
many decades differences in cancer incidence and mortality have been observed between 
urban and rural communities, with the risk of cancer mortality higher in urban dwellers 
(Doll, 1991). Educational level, a social status indicator, has been shown to be directly 
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and indirectly related to several types of cancer (Faggiano et a!., 1995). Higher levels of 
physical activity have also been suggested to reduce the overall incidence of cancer 
(Shephard, 1995). 
Environmental contaminants such as pesticides have been implicated in some 
investigations. The intensive use of persistent organochlorine chemicals, both in 
agriculture and industry, has led to widespread contamination of the environment, and 
residues are found at every level of the food chain (Hayes, 1975). High levels of these 
compounds have been found in human adipose tissue, serum and milk. Although many 
industrial countries have restricted or banned the use of various organochlorine 
chemicals, significant amounts of these pesticides are still being used in many developing 
countries (Kashyap et aI., 1993). 
One particular organochlorine that has been the subject of considerable research is 
dichloro-diphenyltrichloroethane (DDT). This lipophilic compound has a long half-life 
and thus is metabolized very slowly by humans, so that DDT metabolites, including 
DDE, are detectable in the fat and sera of people long after exposure has ended. The 
widespread agricultural use of DDT in the US began in 1945. In June 1972, the 
Environmental Protection Agency (EPA) banned all crop uses of DDT primarily because 
amounts were building up in the environment and because some carcinogenic tests in 
laboratory animals showed positive results (Clement, 1989). Despite a public health 
interest, relatively few epidemiological studies on the possible DDT -cancer association 
have been completed and they have provided inconsistent results. 
The Charleston Heart Study provided the opportunity to examine some of these 
putative cancer risk factors in an ethnically diverse population with a long term follow-
up. The epidemiological study was designed to focus on a variety of environmental 
factors as recorded at the initial examination of the Charleston Heart Study cohort in 
order to identify potential predictors for cancer incidence and to contribute further 
understanding of the possible link between DDT and cancer. The cohort also provided 
the opportunity to assess the utility of self-reported pesticide exposure with risk of 
cancer. 
Specific Aims 
The goal of the study was to quantify the association of putative environmental 
risk factors with cancer morbidity and mortality in a population based cohort. The study 
was designed to test the hypothesis that serum DDE level is a risk factor for cancer, 
specifically breast and prostate cancer. Additional exploratory analysis focused on a 
variety of environmental factors to identify potential risk factors for cancer mortality. 
Using data collected as part of the ongoing Charleston Heart Study, the specific 
alms were: 
1. To describe the cancer mortality patterns with reference to environmental 
factors collected at the 1960 baseline or 1963 re-examination, including 
a. place of residence 
b. occupation 
c. educational attainment 
d. source of water supply 
e. physical activity level, and 
f. tobacco use; 
2. To quantify the association between pesticide exposure and cancer mortality 
USIng: 
a. self-reported use' of pesticides 
b. serum DDE levels 
and to compare the utility of self-reported data; 
3. To test the hypothesis that an increased risk of breast and prostate cancer are 
associated with high levels ofDDE. 
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II. Background and Significance 
Cancer Incidence 
Cancer of some form strikes more than one third of the population, accounts for 
more than 20 percent of all deaths, and in developed countries is responsible for more 
than 10 percent of the total cost of medical care. Over one million new cases are 
identified each year in the United States and approximately 500,000 people die (Ruddon, 
1995). Over the past few decades incidence rates for all types of cancer combined have 
increased in the U.S. For the time period 1973-1991, there was a 31 percent increase in 
cancer among white men, a 15 percent increase among white women, a 34 percent 
increase among black men and an 18 percent increase among black women (Ries et aI., 
1994). Overall cancer incidence (1987-91) was highest among black men (557.2 per 
100,000) followed by white men (464.0), white women (348.0) and black women (331.8) 
(Ries et al., 1994). The largest increase in cancer incidence has been observed in the 
older population, those aged 65 and older. This segment of the population has rates that 
increased over 30 percent between 1973 and 1991(Ries et al., 1994). 
Although the overall cancer incidence has increased, there are differences in rates 
associated with various specific cancers. The rates also vary somewhat by ethnicity. 
Since the mid-1980s, lung cancer incidence rates have reached a plateau while prostate 
cancer has continued to increase. For both black and white men, the prostate gland is the 
most common site of cancer, followed by lung cancer as the second most common site, 
and colorectal cancer as the third most common site. Bladder cancer is the fourth most 
commonly diagnosed cancer in white men, but ranks only ninth for black men (Harras et 
aI., 1996). 
For both black and white women, breast cancer is the most common site of 
occurrence. Lung cancer is the second most frequently occurring type followed by 
colorectal for white women; colorectal is the second highest for black women and lung 
cancer ranks as third. The fourth most common site for both black and white women is 
corpus uteri (Harras et aI., 1996). 
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Not only are there differences in rates across race-sex groups, there is also a 
variation worldwide. For men, the recent overall cancer incidence rates ranged from 
493.8 per 100,000 in Australia, to a low of 59. 1 in The Gambia (Parkin et al., 1992). 
Incidence rates for U.S. men are 351.1 for blacks and 330.4 for whites (Ries et aI., 1994). 
For women, the overall incidence rates ranged from a high of345.4 per 100,000 
in British Columbia, Canada to a low of39.6 in The Gambia (Parkin et al., 1992). The 
comparable rate for u.S. white women is 277.0 and the rate for black women is 227.1 per 
100,000 (Ries et aI., 1994). 
Cancer Mortality 
From 1973 to 1991, the overall cancer mortality rates have increased between 
seven and eight percent (Ries et al., 1994). The number one cause of cancer death in the 
u.s. is cancer of the lung and bronchus. Lung cancer is the number one cause of death 
for white men and women as well as for black men. Among black women, breast cancer 
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mortality rates are slightly higher than the rates for lung cancer. For both white and black 
men, prostate cancer is the second most common cause of cancer death followed by 
colorectal cancer. For both white and black women, the three most common sites for 
mortality are lung, breast and colon cancer. As noted earlier, breast cancer mortality is 
slightly higher for black women than for white women; however, if lung cancer trends 
continue upward, it is expected that lung cancer mortality will surpass breast cancer 
mortality for black women as it has done for white women (Harras et al., 1996). 
As with cancer incidence, there seems to be a dual impact of cancer mortality on 
older people. Not only are mortality rates much higher in the older groups, they are also 
increasing (Harras et al., 1996). There has been more than 14 percent increase in the 
mortality rates in those over 65 years of age from the time period of 1973 to 1991 (Ries et 
aI., 1994). 
Examination of the death rates for all cancer sites combined provide evidence of 
the variation in cancer by country and sex. For men, there is a four-fold difference 
between the countries with the lowest (54.4 per 100,000 in Thailand) and the highest 
(235.4 in Hungary) cancer mortality rates. The difference in women is almost four fold, 
with the lowest (36.4) occurring in Thailand and the highest (139.4) occurring in 
Denmark (Parkin et aI., 1992). Compared with 50 countries, U.S. men rank 24th (163.2 
per 100,000) and women rank 17th (109.7 per 100,000) in regards to mortality rates (Ries 
et aI., 1994). 
Comparison of specific c"ancer mortality rates show that U.s. men rank 12th in 
lung cancer mortality and females rank fourth. Belgium has the highest lung cancer 
mortality rate for males; Scotland has the second highest rate for men and the highest for 
women (Parkin et al., 1992). Within the U.S. there is geographical variation among lung 
cancer deaths; men in the South have the highest mortality rates while females on the 




Breast cancer is the most commonly occurring cancer among both white and black 
women. In 1994, there were approximately 182,000 new cases of breast cancers and 
46,000 deaths from the disease (Kosary et aI., 1995). Examination of incidence rates 
reveals a significant increase in 1974. This increase may have been due to an increased 
awareness for screening since the rates subsequently fell. However, in the period of 1980 
to 1987, the rate increased from 85.2 per 100,000 to 112.4, and then leveled off. These 
increases have been observed in both younger and older white and black women (Kosary 
et aI., 1995). 
Considerable variation in incidence rates occurs among major racial/ethnic groups 
in the US. Above 40 to 45 years of age, white women have the highest rates, followed by 
black women. At younger ages, black women have slightly higher rates than white 
women (Kelsey & Honl-Ross, 1993). 
Possible Etiologic Pathways 
The etiology of breast cancer is not completely understood and is undoubtedly 
complex. Presence of the breast cancer gene, BRCA1, accounts for less than five percent 
of cases. Genetic inheritance and all other characteristics, or risk factors, known to 
increase susceptibility explain only about a third of all cases (Davis & Bradlow, 1995). 
Existing evidence strongly indicates the importance of ovarian hormones in the 
pathogenesis of breast cancer (Henderson & Bernstein, 1996). One feature that is 
common to the known risk factors for breast cancer is an elevated total lifetime exposure 
to estrogen (Kelsey & Hom-Ross, 1993). Table 1 lists some of the characteristics 
associated with increased and decreased levels of estrogen. 
Table 1 
Factors Associated with Estrogen Levels 
Factors which lead to increased exposure to estrogen 
Early menarche 
Late menopause 
Obesity (postmenopausal women) 
Hormone replacement therapy 
Factors which lead to a decreased exposure to estrogen 
Early first-term pregnancy 
Lactation 
Physical activity 
It is believed that ovarian hormones are not genotoxic but affect the rate of cell 
division, thus increasing the risk of breast cancer by accelerating mitotic activity of the 
breast epithelial cell (Henderson & Bernstein, 1996). Recent advances in the molecular 
biology of cancer have provided a basis for the concept that cell division is essential in 
the genesis of human cancer (Henderson & Bernstein, 1996). This "out of control" 
~ 
division is believed to require the accumulation of mutations in genes that regulate cell 
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division and ensure the accurate replication of DNA. Hormones and other substances 
around the cell can also prompt abnormal cell growth (Davis & Bradlow, 1995). 
9 
Estrogens, in particular 17 ~-estradiol, have the ability to induce replication of 
epithelial cells in mammary tissue (Jordan, 1986). This hormone influences cell growth 
by binding to an intracellular protein known as the estrogen receptor. Complexes of 
hormone and receptor bind to DNA in the nucleus and activate certain genes that enhance 
cell division. Enhanced cell replicating and by inference DNA replication, increases the 
probability that a potentially carcinogenic mutation will occur and go unrepaired (Jordan, 
1986). 
The metabolic fate of estradiol in humans is largely determined by the relative 
activities of two cytochrome P450-dependent enzymes that hydroxylate the parent 
estrogen at either the C-16a or the C-2 position (See diagram Figure 1). Several studies 
have demonstrated a marked difference in the estrogenic activity of 2-hydroxylated and 
16a-hydroxylated estrogens. The 2-hydroxylated products possess little estrogenic 
activity. In contrast, the 16a-hydroxylated product binds extensively and irreversibly to 
the estrogen receptor in cell culture studies (Michnovicz & Bradlow, 1990). 
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Figure 1 
Metabolism of Estradiol to 160.- or 2- Hydroxyestrone 
CH 
CH 
It is suspected that increased production of 16-alpha hydroxyestrone increases the 
risk of breast cancer. The 2-hydroxyestrone only weakly activates the estrogen receptor; 
while the 16-alpha metabolite strongly increases the interaction of the estrogen receptor 
with growth promoting genes and possibly enhances breast cell proliferation (Davis & 
Bradlow, 1995; Bradlow et al., 1986). Evidence for this has been demonstrated in animal 
studies and also in recent human trials that have linked elevated levels of 16-alpha 




In the mid-1980s there was a shift in the ordering of the most frequent types of 
cancer. There was an increase in prostate cancer and a leveling off of lung cancer 
incidence rates which resulted in prostate cancer becoming the number one cancer among 
men (Harras et aI., 1996). The number of prostate cancers has continued to increase. In 
1994, there were approximately 240,000 new cases of prostate cancer with 40,000 deaths 
(Ries et al., 1994). 
It has been shown that the survival of men with untreated first stage prostate 
tumor is similar to that of men who are disease free and of the same age. This finding is 
not surprising considering autopsy studies have shown that 20% of 60-year old men have 
microscopic foci of prostate cancer (Byrne et aI., 1996). More than 750/0 of patients with 
prostate cancer survive at least 5 years after diagnosis (NCI, 1992). There is a racial 
difference in survival with white men having an advantage (Ries et aI., 1994). The lower 
survival in black men may reflect differences in stage at diagnosis, but other risk factors 
may also playa role in the racial disparity. 
The international pattern of prostate cancer ranges from low rates in Asian 
countries to the highest rates in North European and American countries. More that 80% 
of cases of prostate cancer are diagnosed in men older than 65, and black men have the 
highest incidence in the world (Greco & Kulawiak, 1992). 
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Possible Etiologic Pathways 
Apart from the nine percent of men with hereditary prostate cancer, the strongest 
risk factor for the development of prostate cancer known to date is age (Carter et aI., 
1992). Existing evidence strongly indicates the importance of endocrine function in the 
etiology of prostate cancer. Circulating androgens are essential for the growth of the 
normal prostate gland and for the development of benign prostatic hyperplasia and 
prostate cancer change. Although the precise role of androgens in terms of carcinogenesis 
is unclear, however they seem to act by promoting cell growth and division (Taplin et al., 
1995). 
Testosterone is metabolized within the prostate to dihydrotestosterone (DHT) by 
the enzyme 5-alpha reductase. DHT is the major intracellular androgen that promotes 
growth within the prostate (Bruchovsky & Wilson, 1968). About 90 percent of the 
testosterone which diffuses into the prostate is converted to DHT (Coffey, 1979). The 
precise role ofDHT in the promotion of prostate cancer is unclear. However, prostate 
cancer has been shown to be absent in pseudohermaphrodite men in whom 5-alpha 
reductase is absent (Kirby et aI., 1996). It is possible that the geographical variation of 
prostate cancer might be related in some way to different levels of DHT in ethnic groups. 
In particular, a reduced activity of 5-alpha reductase has been reported in Japanese men; 
this could account for the lower, but rising, prevalence of prostate cancer in Japan (Ross 
et al., 1992). A number of studies comparing circulating testosterone levels in men with 
prostate cancer to controls of similar age with no known prostate disease have provided 
inconsistent evidence (Ross & Schottenfeld, 1996). 
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The exact role of estrogens in the prostate remains unknown, although it has been 
suggested that they synergistically promote biological effects of androgens (Griffiths & 
Khoury, 1994). Recent research indicates an important role of several growth factors 
which have been derived from the prostate in the pathogenesis of prostate cancer (Calais 
de Silva, 1994). Despite major understanding of the endocrine and biochemical processes 
in regulating prostatic growth, there is no consistent evidence of one primary endocrine 
disturbance that is implicated in the genesis of all prostate cancers (Griffiths & Khoury, 
1994). 
Selected Environmental Risk Factors and Cancer 
For the purpose of this study, the term environment includes the measured 
characteristics that are not considered to be genetically determined. Cancer risk may be 
influenced by many factors, including both environmental factors and genetics. Genetic 
predisposition acting in isolation probably explains no more than 5% of all cancers in the 
u.s. (Venitt, 1994). Some of the environmental factors suggested to be risk factors for 
cancer incidence and mortality include tobacco use, alcohol consumption, diet, 
occupation, pollution, selected consumer products, exposure to medical drugs, sexual 
development, reproductive patterns and sexual practices, radiation, infection and other or 
unknown associations (Westview Press, 1982). It has been suggested that socioeconomic 
factors, including educational attainment, residence, occupation, behavioral patterns, and 
income contribute to cancer mortality (Schrijvers & Mackenbach, 1994). This study was 
~ 
used to examine the relationship between some of these putative risk variables that were 
collected more than 35 years ago with cancer mortality in a community based cohort. 
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Tobacco Use 
Worldwide an estimated one billion people smoke cigarettes. Other tobacco 
practices are also widespread, including the smoking of pipes or cigars (Council on 
Scientific Affairs, 1990). Over 2000 chemical compounds have been identified in the 
tobacco leaf, and many others are formed during smoking (Dube & Green, 1982). The 
cancer risks associated with tobacco use have been extensively investigated. Tobacco 
use, particularly in the form of cigarette smoking, is the single most preventable cause of 
excess mortality in the U.S. Epidemiologists have attributed as many as 25% to 40% of 
all cancer deaths to tobacco use (Ruddon, I 995). Among male cigarette smokers, the risk 
of lung cancer is more than 20 times higher than among male nonsmokers; for women, 
the risks are approximately 12 times greater (Shopland, 1996). 
It has been suggested that cigarette smoking does not substantially affect the risk 
of breast cancer in women (Wald & Baron, 1990; Palmer & Rosenberg, 1993). Smoking 
produces an anti-estrogen effect, increasing the risk of several estrogen-related diseases 
including osteoporotic fractures and endometrial cancer (Baron, 1984). Data do not 
suggest any differences in circulating estrogen levels in postmenopausal smokers 
compared to nonsmokers (Barrett-Conner & Khaw, 1990). Separate analysis of breast 
cancer in premenopausal and postmenopausal women do not revealed an effect of 
smoking in either group, as neither have investigations of estrogen receptor positive or 
negative tumors (Palmer & Rosenberg, 1993). Additionally researchers report that 
cigarette smoking is not associated with the proliferative breast lesions which are strongly 
linked with breast cancer (Rohan et aI., 1989). 
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Most investigations of prostate cancer and cigarette smoking have reported no 
association (Cederlof et aI., 1975; Doll & Peto, 1976; Garfinkel, 1980; Hirayama, 1990; 
Talamini et aI., 1993). However, there have been some which have noted increased risks, 
particularly among heavy smokers (Honda et aI., 1988; Hsing et al., 1991; Hiatt et aI., 
1994). Circulating testosterone levels have been found to be higher in cigarette smokers 
than in nonsmokers; although the differences were not large and not dose related (Dai et 
al., 1981; Deslypere & Vermeullen, 1984; Barrett-Conner & Khaw, 1990). 
Water Sources 
Although the quality of drinking water in industrialized nations is looked upon as 
the best in the world, there is growing concern that various contaminants may contribute 
to the burden of environmental carcinogenesis (Cantor et aI., 1996). Drinking water 
contains complex mixtures of known and suspected carcinogens, including asbestos, 
metals, radioactive substances and industrial chemicals (Cantor, 1990). Water pollution 
can occur through chlorination, from by products of manufacturing facilities, agriculture, 
logging sites, mining facilities, power generators, and hazardous waste disposal sites 
(Swanson, 1988). There is no evidence to indicate an increased or decreased risk of 
breast or prostate cancer with the quality or source of drinking water. 
Occupation 
Studies of occupational groups have played a key role in identifying potential 
causes of human cancer. Occupational studies have been particularly useful because they 
are comprised of defined popUlations on whom exposures can be monitored and 
identified. 
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The first recognized cancer associated with occupational exposure was identified 
by Percival Pott, a British surgeon who observed that scrotal cancer occurred more 
frequently in men who had been employed as chimney sweeps during their boyhood. 
This observation led to the identification of soot components as the first chemical and 
occupational carcinogens (Westview Press, 1982). Since then many other groups of 
workers have been found to experience cancer resulting from occupational exposure. The 
agents which have been identified as either carcinogenic or probably carcinogenic to 
humans include metals, solvents, organic and inorganic dust, chemicals used to construct 
polymers, and pesticides (IARC, 1987). Appendix A contains a list of occupational 
groups which have experienced an excess risk of cancer (Monson, 1996). From this list it 
is apparent that lung cancer was the type of cancer most often associated with an excess 
risk for the various occupation groups. 
The relationship of occupational exposures in women has only recently been 
investigated. Several studies have shown high rates of breast cancer in school teachers 
and nurses, probably owing to their higher socioeconomic status and reproductive 
histories, such as older age at first pregnancy (Brinton & Devesa, 1996). A recent 
conference on occupational risks among women suggested possible breast cancer links 
with employment in the printing and publishing, telephone, and electrical equipment 
manufacturing industries (Pottern et al., 1994). 
Cadmium has been the focus of many occupational studies concerning prostate 
cancer. Cadmium, a non-essential trace element, is a zinc antagonist in biological 
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systems (Gunn et aI., 1961). Because zinc is involved in the regulation of cell growth and 
is concentrated heavily in prostatic tissue, it has been suspected that accumulation of 
cadmium in the prostate might interrupt normal cell growth and result in cancer (Kolonel 
& Winkelstein, 1977). Early epidemiological studies provided some limited support for 
this hypothesis (Kipling & Waterhouse, 1967; Kolonel & Winkel stein, 1977). Other 
studies have been unable to confirm any association between prostate cancer risk and 
cadmium exposure (Armstrong & Kazantzis, 1985). 
Several investigators have suggested that farmers are at a higher risk of prostate 
cancer. Blair and Zahm reviewed 24 occupational cohort studies and surveys to 
determine if there was evidence of an association between prostate cancer and pesticide 
exposure. They found that ten of the 24 studies had a significant elevated risk while only 
one reported a significant lower risk. The range of the relative risks for all twenty-four 
studies was 0.9-2.0 (Blair & Zahm, 1991). 
Residence 
Differences in cancer incidence have been observed between urban and rural 
communities for many decades (Clemmesen, 1969; Bako et al., 1984; Muir et al., 1987; 
Doll, 1991; Nasca et at, 1992; Friis & Storm, 1993; Howe et al., 1993). In general the 
risk of cancer has been higher in urban populations. The excess risk in urban 
communities was greatest for cancers of the bladder, larynx, liver, lung, mouth and 
pharynx, and esophagus. Differences in personal behavior (tobacco and alcohol use, 
sexual promiscuity, exposure to ultraviolet (UV) light, type of diet and family size) have 
been hypothesized as the principal factors responsible for the excess risk among urban 
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residents. A rural excess for cancer of the lip has been observed (Doll, 1991). Cancer of 
the lip and non-melanoma skin cancer are thought to be caused by exposure to UV light; 
people in rural areas are more likely to be exposed to UV radiation because of their 
greater likelihood of working out of doors (Schouten et aI., 1996). 
It has been shown that residency in urban areas is associated with an increased 
risk of breast cancer (Brinton & Devesa, 1996). This may be explained because breast 
cancer generally occurs more often among women of the upper social classes. It has been 
suggested that socioeconomic, reproductive and dietary factors which are all associated 
with the place of residency, may playa role in breast cancer (Jacobsen & Lund, 1990). 
Prostate cancer has been shown to be less likely to develop in men living in a rural 
environment than in their counterparts living within urban areas. Futhermore urban 
residents have also been at greater risk of dying from the disease (Blair & Fraumeni, 
1978). The factors responsible for the difference in residence could be possibly attributed 
to general environmental pollution by chemical agents, as well as exposure to substances 
within the work place (Kirby et al., 1996). 
Education 
The distribution of cancer within society is complex but is associated with a set of 
risk factors (occupation, diet, personal habits) whose prevalence is a function of the social 
stratification of a society. Educational level has been used as a social status indicator in 
several studies of cancer mortality (Faggiano et al., 1995). Numerous studies have 
confirmed an inverse relationship between cervical cancer and education (Faggiano et al., 
1995; Corral et al., 1996). Other cancers shown to be associated with educational level 
include colon, pancreas and bladder (Faggiano et al., 1995; Vizcaino et aI., 1994). In 
each case there was an inverse relationship between educational level and cancer risk. 
19 
There has been a direct relationship observed between breast cancer and 
educational status (Jacobsen & Lund, 1990). Breast cancer is a disease that has been 
shown to occur more often among women of the upper social classes, as measured by 
either educational status or family income (Krieger, 1990). This association largely 
reflects the effect of correlated life-style factors, such as later ages at first birth (Jacobsen 
& Lund, 1990). 
No clear relationship has been observed between the risk of prostate cancer and 
educational attainment. The possible relationship between socioeconomic characteristics 
and prostate cancer has been examined in a variety of ways, including occupational data 
obtained from death certificates, family income and educational level. These studies 
reported no large differences in prostate cancer risk between men in the highest compared 
to those in the lowest strata, no matter how socioeconomic status was defined (Seidman, 
1970; Ernster et al., 1977; Baquet et al., 1991). 
Physical Activity 
A growing number of well controlled studies have suggested that both hard 
physical work and an active leisure lifestyle reduce the overall incidence of cancer 
(Shephard, 1995). A recent study suggested exercise may help prevent certain cancers 
(Mackinnon, 1994). Colon cancer has been suggested as the most prevalent cancer that 
could be reduced by physical activity (Giovannucci et aI., 1995). 
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Little attention has focused on the role of physical activity and breast cancer even 
with the growing concern of the effects of body size and dietary factors on breast cancer 
risk. One study found reductions in risk of early-onset breast cancer associated with 
regular physical activity, independent of body size (Bernstein et al., 1994). This 
relationship seemed plausible because physical activity can modify menstrual cycle 
patterns and alter the production of ovarian hormones (Brinton & Devesa, 1996). 
However other studies have failed to find an association of breast cancer risk and physical 
activity (Dorgan et aI., 1994; Paffenbarger et aI., 1987). 
The relationship between physical activity and prostate cancer is unclear. There is 
some evidence that physical activity is associated with other prostate cancer risk factors. 
Recent investigations have suggested decreased regular physical activity is associated 
with increased endogenous circulating testosterone levels, increased fat distribution, and 
body mass index (Thune & Lund, 1994). However previous studies reported conflicting 
conclusions about whether decreased recreational and occupational physical activity was 
an independent risk for prostate cancer (Paffenbarger et aI., 1987; Severson et al., 1989; 
LeMarchand et aI., 1991; Hsing et al., 1994). 
DDT Exposure 
DDT (dichlorodiphenyl trichloroethane or 1,1, I-trichloro-2,2-bis(p-chlorophenyl) 
ethane) was one of the most popular chemicals used for controlling insects. Technical 
DDT is a mixture of three forms: p,p'DDT, o,p'DDT, and o,o'DDT. DDT was fIrst 
synthesized in 1874, and its insecticide properties were discovered in 1939. It was used 
for controlling insects in agricultural areas and controlling insect borne diseases such as 
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malaria. In 1972, the Environmental Protection Agency banned the use of DDT within 
the United States because amounts were building up in the environment and carcinogenic 
tests in animals showed positive results (Van Ert & Sullivan, 1992). 
DDT persists in the environment for long periods of time following its application 
to soil and is converted to DDE, which persists even longer. DDT and its primary 
metabolites, DDE and DDD, have been found at hazardous waste sites on the National 
Priorities List in the US (Van Ert & Sullivan, 1992). DDT is still used in agriculture and 
for disease control in other countries, including Mexico, and direct release to the 
environment, movement of residues through the environment, and contamination of 
imported goods may result in potential low-level exposure to the u.s. population (Van 
Ert & Sullivan, 1992). Also, due to the extensive past use of DDT worldwide and its 
biological persistence, these materials are virtually Ubiquitous and are continually being 
transformed and redistributed in the environment (Clement, 1989). 
DDT and its metabolites are found in samples of human blood, adipose tissue, 
breast milk, umbilical cord blood and placental tissue. DDT and DDE bioaccumulate in 
the food chain and human exposure results primarily from ingestion of meat, fish, poultry 
and vegetables. Ingested DDT undergoes reductive dechlorination to DDD and DOE, 
although the latter at a slower rate, and therefore DDE is usually used as a biomarker for 
past exposure to DDT (Van Ert & Sullivan, 1992). DDT and DDE are stored most 
readily in adipose tissue and leave the body slowly through excretion in breast milk and 
urine. It has been shown that adipose tissue levels and blood levels of ODE are highly 
correlated (Stellman et aI., 1997). 
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Animal studies have demonstrated the hormonal properties of DDT. One isomer, 
o,p'DDT, possesses estrogenic properties. It has been shown to affect uterotropic activity 
and produce an increase in uterine glycogen content in the rat (Bulgar & Kupfer, 1985). 
Others have found that p,p'DDE has little ability to bind to the estrogen receptor, but it 
inhibits androgen binding to the androgen receptor, androgen induced transcriptional 
activity and androgen action in developing, pubertal and adult male rats (Kelce et al., 
1995). These findings in animals suggest that DDT and its metabolites have the capacity 
to interact with both the estrogen receptor and androgen receptor, increasing the risk for 
hormone-related cancers and reproductive disorders. 
Possible Association of Cancer and DDT 
Several studies have investigated the possible mechanisms for carcinogenesis 
associated with DDT exposure. Inhibition of apoptosis is one possible mechanism 
whereby exposure to DDT may suppress the normal process of cell death and thus 
promote neoplastic cell division (Wright et aI., 1994). Another avenue may be through 
the estrogenic properties of the o,p' isomer. Through binding to the estrogen receptor it 
may mimic the action of estradiol, which stimulates cell proliferation and increase the 
risk of hormone-related cancers. A third mechanism may involve a system of enzymes, 
since DDT is a known inducer of cytochrome P450 enzymes which mediate the 
metabolism of estrogen. Studies suggest that DDT may induce the P450 enzyme that 
carries out the metabolism of estradiol to 16 alpha-hydroxyestrone which has been shown 
to increase the risk of breast cancer (Davis & Bradlow, 1995). A recent investigation 
found that DDE has the traits of a potent antiandrogen in rats (Kelce et al., 1995). The 
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possible consequences of inhibition of androgen receptor binding and of subsequent 
transcriptional activity are similar to the dangers posed by environmental estrogen (Kelce 
et aI., 1995). 
DDT is classified as an animal carcinogen and evaluated as possibly carcinogenic 
to humans by the International Agency of Research for Cancer (IARC, 1987). Appendix 
B contains a summary of the epidemiological studies done thus far regarding cancer and 
DDT. Most of the literature addressing human carcinogens and pesticides has focused on 
occupational exposures. Many of these studies, however, present conflicting results or do 
not report on specific chemicals. The few population studies that have been conducted 
reported inconsistent results comparing levels of DDT in those with and without cancer. 
The purpose of our study was to evaluate the DDT -cancer association previously 
reported by other investigators. There have been several small case-control studies thus 
far that have investigated the potential effect of an increased risk of breast cancer with 
higher levels ofDDE and DDT, and they have reported differing results. Wassennan et 
al. examined adipose tissue from 9 women with breast cancer and 5 post-mortem 
controls. They found higher p,p'DDE levels in the breast tissue of control patients 
compared to malignant tissue in the cases (1976). Unger et al. found no differences in 
DDE levels using two different case control studies (1982). The first study compared the 
DDE levels in adipose tissue taken at autopsy from 18 women with breast cancer to the 
levels in adipose tissue taken at autopsy from 35 women without breast cancer. The 
second study included tissue taken from 14 women with breast cancer and from 21 
women with other breast abnormalities at the time of surgery. After controlling for age 
the investigators found no difference in DDE levels in either study (1984). Mussalo-
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Rauhamaa et aL reported the findings from a case-control study of adipose tissue taken 
from 44 women with breast cancer and 33 post-mortem controls. They also found no 
differences in p,p'DDT or p,p'DDE levels between the groups (1990). Falck et al. 
examined the levels in adipose tissue from 20 women with breast cancer compared to 20 
controls with other breast abnormalities and found no significant differences after 
adjusting for age, body mass and smoking (1992). More recently, DeWailyet al. have 
reported higher DDE levels among 9 breast cancer patients with estrogen receptor 
positive tumors when compared to biopsy material from 17 control patients with other 
breast abnormalities. There was no difference in DDE levels between the women with 
estrogen receptor negative tumors compared to the controls (1994). 
Results from several larger epidemiologic studies have been published. Wolff et 
a1. reported statistically significant findings from a case-control study of 58 women with 
breast cancer and 171 controls (1993). After adjustment for a number of known risk 
factors, they found a significant positive association between serum DDE levels and 
breast cancer. Given the limited follow-up time of 6 months, it is likely that most of the 
breast cancers had occurred prior to enrollment into the cohort, which means breast 
cancer was probably present at the time the blood was drawn. This is a potential bias 
because the uncertainty of whether the disease came before the exposure is not known. If 
organochlorine concentrations are altered because of the disease process, their 
conclusions may not be valid. 
Krieger et a1. reported on a study of women in the Northern California Region 
Kaiser Permanente Medical Care Program, and they concluded that there was no 
association between DDE levels measured from frozen sera and subsequent development 
of breast cancer (1994). Serum specimens were obtained from 1964 to 1969 and breast 
cancer was ascertained from the time of the examination through 1990. One hundred 
fifty cases were randomly selected and compared to an equal number of ethnic and age 
matched controls. The levels of serum DDE were higher among black women who 
developed cancer than among black women without cancer, while the trend was in the 
opposite direction for Asian women, and there was almost no difference between cases 
and controls among the white women. Thus far, this was the only other longitudinal 
study of DDT and breast cancer using serum collected well before the onset of breast 
cancer with over twenty years of follow-up. 
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A recent study conducted by Hunter et a1. examined participants in the Nurses' 
Health Study for an association between DDE and breast cancer. Plasma levels ofDDE 
were measured on 236 women who gave a blood sample in 1989 or 1990 and who were 
subsequently diagnosed with breast cancer before June 1, 1992. These levels were 
compared with those measured in matched control women in whom breast cancer did not 
develop. The mulivariate relative risk of breast cancer for women in the highest quintile 
of exposure as compared with women in the lowest quintile was 0.72 (CI: 0.37-1.37). 
Exposure to high levels of DOE was associated with a nonsignificanly lower risk of 
breast cancer (Hunter et al., 1997). The results from this prospective study agreed with 
Krieger's et al. findings of no association. 
Other researchers concentrated on the risk of postmenopausal breast cancers. A 
study of 154 incident postmenopausal breast cancer cases and 192 postmenopausal 
community controls showed no association of serum levels ofDDE and breast cancer. 
(OR = 1.49; 0.73-3.04) (Moysich et aI., 1997). 
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The epidemiological investigations that have been completed thus far have not 
been able to examine a direct relationship between prostate cancer and DDT levels, but 
they have examined a cohort of individuals occupationally exposed to various pesticides 
(Blair,1991). These studies have shown that farmers have an increased risk for prostate 
cancer. These tumors, present at higher rates in farmers, are also increasing in the general 
population. These studies suggest that the relationship of increased use of pesticides, 




The subjects for this study were members of the Charleston Heart Study, a 
prospective cohort study which was begun for the investigation of cardiovascular risk 
factors among black and white adults. A cross-sectional survey of the Charleston County 
population 35 years of age and older was devised during 1959 by Drs. E. Boyle, R. V. 
Moore, and M .Z. Nichaman for obtaining prevalence data. The sample was based on 
the 1950 census and was drawn by Dr. Alva Finkner of the Research Triangle Institute of 
Durham, NC. The county was divided into the city proper, the urban fringe, the open 
country and rural places. These areas were subdivided into units of twelve households 
each. One hundred and sixty units were selected. All adults 35 years of age and older 
were approached for recruitment into the study (Boyle et al., 1967). 
The survey was physically conducted in the Charleston community between April 
1960 and December 1961. A mobile trailer was utilized to examine the study subjects (at 
their place of residence) by a staff consisting of a registered nurse, public health advisor 
and supervising physician. Community acceptance of the study was encouraged by 
newspaper, radio and television publicity, and by letters soliciting aid from ministers and 
school principals. Repeated attempts were made to obtain cooperation from reluctant 
subjects (Boyle et aI., 1967). 
Response 
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The area sampling plan yielded a total sample of2601, of whom 2184 responded. 
Three persons of "other" ethnic groups were found in the sample and eliminated from 
further consideration, decreasing the sample to 2181 persons. This represented an overall 
84% response rate and showed insignificant variations by age, race and sex. 
Baseline exam 
The 2181 persons who participated in the baseline examination included 653 
white men, 741 white women, 333 black men and 454 black women. Demographic data 
were collected on each subject, such as educational attainment and geographic family 
origin. An abbreviated medical history was obtained. An electrocardiogram and 
venipuncture were also performed. The blood obtained was analyzed for serum 
cholesterol, beta lipoprotein, type (A, B, 0, AB) and hemoglobin electrophoresis. 
A structured interview at the baseline examination was used to determine 
residence, occupation, education, and tobacco use. The following table contains the 
questions asked of each participant for obtaining these specific data. Occupation was 
recorded as indicated by the participant and later coded by the investigators into the 
categories listed in the table. Education was later recoded to reflect the total number of 
years of attainment. 
Table 2 
Excerpts from the Baseline Questionnaire (1960) 
Residence 
Where did you live the first 20 years of your life? 
Urban Rural Mixed 
Where did you live from age 20-65 ? 
Urban Rural Mixed 
Occupation 
What is/was your Occupation? ________ _ 
O. Professional 
1. Military service personnel 
2. Farmers and farm managers (owners & tenants) 
3. Proprietors, managers and officials (non-farm) 
4. Clerical, sales, and kindred workers 
5. Craftsmen, foremen, and kindred workers 
6. Operative and kindred workers 
7. Protective service workers and service workers 
8. Farm laborers and foremen 
9. Laborers except farm and household 
10. Housewives 
Education 
What is the highest level of education you have completed? 
Elementa-ry: 1 2 3 4 5 6 7 8 
High School: 1 2 3 4 
College: 123 4 
Tobacco Use 
Do you use tobacco? _ Yes _No Years using __ _ 
If no, ever used it? __ Yes _ No Years since use --
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Follow-Up Exams and Interviews 
The following sections describe the overall purpose and number of subjects who 
participated in the subsequent follow-up examinations, referred to as phases. The 
descriptions focus only on the information used to address the specific aims for this 
project. 
Phase III (1963) 
In 1963 there was a selective re-examination of 1402 subjects from the original 
cohort. This subsample consisted of273 persons with EKG abnormalities determined 
from the baseline exam. Two controls of the same race, sex, and cholesterol level for 
each subject with an abnormality were also included. Additionally 1152 participants 
were selected from four cholesterol categories ( < 190, 190-229, 230-269, < 270) as 
determined by their 1960 data. This sampling plan resulted in an overlap of 659 subjects 
and in ten instances there was only one control available per subject with an EKG 
abnormality. Another purpose of this recall was to increase the number of high 
socioeconomic (SES) black men since the random selection process used in the initial 
phase yielded an insignificant number in this strata. Inclusion in this socioeconomic 
group was verified by the Maguire social scale which considered occupation, income, 
education and professional attainment, residence location and appearance, and religion. 
This recruitment effort resulted in an addition of 102 high SES black men into the CHS 
cohort, thus increasing the total sample size to 2283 participants. 
The examination procedure consisted of a brief medical history and interview. 
Although the interview solicited some of the same information collected at baseline, such 
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as occupation, education and tobacco use, it was expanded to include questions regarding 
other potentially important exposures and characteristics. The following table contains a 
reproduction of the selected questions from the 1963 interview used in the current study. 
The source of water supply was categorized as either city, surface, artesian or other. 
Physical activity questions were asked to gain information on both current and past level 
of activity. 
Table 3 
Excerpts from the 1963 Questionnaire 
Occupation 
What is/was your Occupation ? __________ _ 
Education 
What is the highest level of education you have completed? __ 
Tobacco Use 
Do you use tobacco? _ Yes _No 
If no, ever used it? __ Yes _ No 
Years using ___ _ 
Years since use ---
Water Supply 
Do you have "city water" in your house? yes 
In no, surface artesian other ---
Physical Activity 
What is your physical activity level now? 
_ sedentary _light __ medium __ heavy _ very heavy 
What was your physical activity level 10 years ago? 
_ sedentary _light __ medium __ heavy _ very heavy 
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Phase VII (1974175) 
In 1974/75, all survivors of the cohort were asked to participate in the coronary 
disease incidence recall. There was a subsample of 1434 members of the cohort who 
chose to comply; yielding an 84 % response rate. At this time a detailed questionnaire 
was administered by trained surveyors and serum samples were collected. Information 
was collected on a number of variables including age, education, body mass index (BMI), 
smoking status and serum total cholesterol. Because of an ancillary interest in examining 
the association between DDT, blood pressure and skin color, three questions regarding 
pesticide use and DDT exposure were asked of each participant. 
Table 4 contains the questions related to pesticide use. 
Table 4 
Pesticide Questions from 1974/75 Questionnaire 
Have you ever worked with pesticides? 
Number of years ____ _ 
Do you use pesticides around the home? 




If yes, give details _______ _ 
Serum samples were collected and p,p'DDE measurements were made by gas 
chromatography using the Dale-Cueto modified method. Measurements were recorded in 
parts per billion with a detection limit of 1 ppb (Dale et al., 1966; Keil et al., 1972). 
DDE measurements were not made on all who were interviewed because only 898 
of the participants, including 319 white women, 84 black women, 300 white men, and 
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195 black men agreed to have their blood drawn. Thus, only 898 subjects who had DDE 
measurements were available for many analyses. Answers to the questions regarding 
pesticides were not answered by two white women, thus decreasing the sample size to 
896 for analyses using these variables. Thirty-four participants failed to answer the 
question, which specifically addressed exposure to DDT. 
Phase X (1984/85) 
The recall in 1984/85 was a 25-year follow-up designed to ascertain the vital 
status of the cohort. While there was no physical exam, a rather detailed questionnaire 
was used to gather updated information on demographics, physical functioning status and 
medical histories. The survivors were contacted by phone to schedule an appointment, 
and then an experienced interviewer made in-house visits to administer the questionnaire 
and record height, weight and blood pressure. A total of 1246 participated in this recall. 
Although a medical history was included, cancer history was omitted. 
Phase XI (1987/89) 
In 1987/89, there was a comprehensive physical examination and assessment of 
functional status for each participant. The survivors of the cohort were contacted and 
asked to come to the Medical University for the examination and interview. Of the 1079 
subjects who were still living: 693 came into the clinic, 176 had home interviews, 126 
had phone interviews, 57 refused and 27 did not participate for other reasons. Questions 
regarding cancer history were included in this interview, and Table 5 lists these questions. 
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Table 5 
Cancer History Questions in 1987/89 
Has a doctor ever told you that you had any of the following diseases? 
If yes, please indicate date of onset. 
Date 
Skin Cancer Yes No DK / ----
Breast Cancer Yes No DK / ----
Bladder Cancer Yes No DK 1 ----
Lung Cancer Yes No DK / ----
Other Cancer Yes No DK / ----
Phase XII (1990/91) 
In 1990/91, survivors of the cohort were again examined for coronary heart 
disease (CHD) and functional status. Of the 965 members still living, 496 came into the 
clinic, 241 required home interviews, 180 had telephone interviews, and 48 refused. 




Cancer History Questions in 1990/91 
Has a doctor ever told you that you had any of the following diseases? 
If yes, please indicate date of onset. 
Date 
Skin Cancer Yes No DK / ----
Breast Cancer Yes No DK / ----
Bladder Cancer Yes No DK 1 ----
Lung Cancer Yes No DK 1 ----
Esophageal Cancer Yes No DK 1 ----
Prostate Cancer Yes No DK 1 ----
Other Cancer Yes No DK 1 ----
Specify 
Phase XIII (1994/95) 
In 1994/95, a follow-up interview was conducted to obtain the vital status and the 
cancer history of the 898 participants who had DDT measurements made in 1974/75, as 
well as from all survivors of the cohort. This follow-up included 345 survivors without 
DDT measurements. All participants were contacted by phone, and if the participant was 
deceased, a proxy was located. There were 659 interviews completed by the participants 
themselves and 584 interviews completed by proxy. For more than half of the deceased 
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subjects, their surviving spouse provided the requested information. In other instances, 
when the spouse was not available, a child or sibling of the deceased served as a proxy. 
The questionnaire was designed to update the subject's medical history, including all 
cancers. Information was obtained so that cancers could be classified by site. Listed 
below (Table 7) are the questions regarding cancer history addressed to both men and 
women. A separate questionnaire, addressed to women only, was designed to obtain 
information on risk factors for breast cancer. These questions are listed in Table 8. 
Table 7 
Cancer History Questions in 1994/95 
Men and Women 
Has a doctor ever told you that you had cancer? 
If yes, please indicate date of onset. 
Cancer No Yes Date: / 
If yes, please provide the following additional information. 
Where was it located? ---------------------
Were you hospitalized? __________ _ 
Which hospital? ____________ _ 
Who was your doctor? __________ _ 
Table 8 
Breast Cancer Risk Factors 1994/95 
Women Only 
How many times have you been pregnant? __ 
How many children have you had? __ Sons __ Daughters 
How old were you when you had your first child? __ 
Did you breast feed your children? No Yes Don't Know 
If yes, how many of your children? __ 
Have any of the following women in your family ever had breast cancer? 
Mother ............... No Yes Don't Know 
Sister .................. No Yes Had no sisters Don't Know 
Daughter ............ No Yes Had no daughters Don't Know 
Has a doctor ever told you that you had benign breast disease? No Yes 
Have you had a hysterectomy? No Yes Don't Know 
If so, how old were you? __ 
Were the ovaries removed? No Yes Don't Know 
Have you ever had a mammogram? No Yes Don't Know 
If yes, When was your last mammogram? _____ _ 
Have you ever taken a hormone replacement? No Yes Don't Know 
If yes, how many years did you use it? 
Summary of Follow-Up Exams 
The outcomes of interest for this project were both cancer incidence and cancer 
mortality. As described in the previous sections, information to determine cancer 
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incidence was obtained in several follow-up periods (phases). These times were 1987/88, 
1990/91 and 1994/95. Mortality is addressed in the following section. 
Mortality 
The vital status of the cohort was monitored through the various recalls of the 
original cohort. The underlying cause of death from nosologists' coding of death 
certificates was used to classify the deaths. International Classification of Diseases, ninth 
revision (ICD9) codes 140.0 through 239.9 (excluding benign neoplasms) were used to 
define cancer mortality. For the period of 1960-1994, there were 294 cancer deaths and 
86% of these were verified by hospital and pathology reports. The remaining 14 % were 
unable to be verified because the medical records were not available. Over the 34-year 
period (1960-1994) there were 52 individuals lost to follow-up. The closing date for this 
study was December 31, 1994. 
Statistical Analysis 
Specific Aim J 
To describe the cancer mortality patterns with reference to environmental factors 




d. tobacco use 
e. water supply 
f. physical activity 
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Descriptive Statistics 
A number of putative risk variables measured in 1960/63 were examined in a 
univariate fashion to determine if they were associated with cancer mortality. For these 
analyses all variables except age were considered categorically: race as white, black or 
high SES black; educational attainment as less than high school, less than college 
graduation, less than advanced degree, or advanced degree; water supply as city, surface, 
artesian, or other; residence as urban, rural, or suburban; occupation as farmers, manager 
and sales, laborer, military, professional, or housewife; physical activity as sedentary, 
light, medium, heavy, or very heavy; current smoking as status as yes or no; and gender 
as male or female. All comparisons for the categorical variables were made using a chi-
square test. If the contingency table had a cell count less than 5, then the p .. value from 
Fisher's Exact test was used. A Student's t-test was used to compare the mean difference 
in age for those dying of cancer to those not dying of cancer. 
Logistic regression models were constructed to test the association of each 
variable with cancer mortality adjusting for age, gender and race. For these analyses, 
education and physical activity were categorized into smaller categories with education 
collapsed into two groups: high school education versus less than high school education 
and physical activity was categorized as high and medium versus light activity. Logistic 
regression was perfonned to determine the magnitude of the effect that a particular 
variable had on the outcome (cancer mortality) while adjusting, or ignoring, the effect of 
the other variables. Logistic regression is a mathematical modeling approach used to 
describe the relationship of several independent variables to a categorical dependent 
variable (Kleinbaum, 1991). In this situation, the dependent variable in the model was 
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cancer mortality status and a series of independent variables were evaluated adjusting for 
the effects of age, race and gender. For example, the model to determine if tobacco use 
was associated with cancer adjusting for the effects of age, race and gender would be 
expressed by the following model: 
Y cancer = Po + ~smokingXsmoking + Page X age + P race Xrace + P sex X sex . 
The P coefficients were unknown parameters that were estimated based on the data 
observed for the subjects. Maximum likelihood estimation procedures were used to 
obtain the estimates of the PI's. Each PI represented the change in the log odds that 
results from a one unit change in the independent variable when all other X's were fixed. 
For dichotomous variables, such as smoking, the values were 0 (no) or 1 (yes). Therefore 
the Psmoking represented the change in the log odds that would result from subjects who 
smoke relative to those who did not smoke while holding the other independent variables 
constant. Thus, the adjusted odds ratio for each dichotomous (0,1) variable in the logistic 
model was obtained by exponentiating the coefficient corresponding to that variable, e.g. 
eP=OR. 
Survival Analysis 
A second approach that incorporated the length of follow-up was used to evaluate 
the association of environmental factors with cancer mortality. Survival analysis, using 
Cox proportional hazard regression, was used to estimate the relative risk of cancer 
mortality. This particular analysis strategy was important because it considered the time 
element inherent in a prospective design. For the models specified, time until death or 
end of study was used to define the time each person was considered at risk. Models 
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were constructed for cancer mortality as the outcome measure, and the independent 
measures included a number of categorical variables: smoking, water supply, occupation, 
residence, physical activity and education. Additional models adjusted for age, race and 
gender. The approach to obtain the relative risk (RR) estimates was not to get the best fit 
of the model, although this was also examined, but rather the focus was on quantifying 
the risk of the putative factors for this cohort. 
Cox proportional hazards modeling has become a popular mathematical tool used 
for analyzing survival data. Briefly described, the Cox model provides an expression for 
the hazard at time 1 for explanatory variables, or predictor variables. This model contains 
two components, a baseline hazard function of time and an exponential function 
involving the explanatory variables but not time. For example, the model to determine if 
tobacco use is associated with cancer adjusting for the effects of age, race and gender is 
represented as: 
h(I,X) = 110 (I) eJ30 + J3 smoking X smoking + f3age X age + J3 race X race + J3 sex X sex. 
The parameters are the ~'s and they are estimated with maximum likelihood (ML) 
procedures. Once the ML estimates are obtained, the interest lies in the statistical 
inferences about hazard ratios defined in terms of these estimates. A hazard ratio is 
defined as the hazard for one individual h(l, X*) divided by the hazard for a different 
individual h(l, X), where X* denotes the set of predicators for one individual and X 
denotes the set of predictors for the other individual. Thus, the hazard ratio is computed 
by exponentiating the sum of each of the estimated f3i'S times the difference between Xi· 
and Xi- The hazard ratio for the effect of a (0,1) variable which adjusts for other variables 
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is obtained by exponentiating the estimated coefficient of the variable (Kleinbaum, 1995). 
For example, the hazard ratio for tobacco use (smoking) is represented as: 
HR = exp [J3 smoking X smoking + J3 age X age + P race X race + P sex X sex] . 
The hazard function, h(t), gives the instantaneous potential per unit time for the event to 
occur, given that the individual has survived up to time t. Note that the hazard function 
focuses on the failure of an event, for example cancer death. The model assumes 
proportionality of the hazard rates, or equivalently, that the hazard for one individual is 
proportional to the hazard for any other individual, independent of time. This assumption 
was verified for our data by creating a time-dependent variable in which the Cox model 
was extended to contain a product term involving the time-independent variable being 
assessed (such as DDE) and some function of time. The null hypothesis for the 
proportionality assumption was that this product term would be zero (Kleinbaum, 1995). 
If the associated p-value was greater than 0.05 then the proportionality assumption was 
verified and the Cox model reduced to its original form (Kleinbaum, 1995). 
Specific Aim 2 
To quantify the association between pesticide exposure and cancer mortality 
uSing: 
a. self-reported use of pesticides 
b. serum DDE levels 
and to compare the utility of self-reported data. 
Self-Reported Use 
As described in a previous section, pesticide use was reported by subjects during 
the Phase VII interview. If anyone of the three questions asked in the interview 
43 
regarding pesticide use was answered "yes" then the individual was considered as being 
exposed to pesticides. If all three questions were answered "no" then the subject was 
categorized as not using pesticides. Contingency tables were constructed to test the 
association of reported use with cancer mortality. Crude relative risks were calculated 
from these tables. The risk estimates were for all subjects and also for each race, sex and 
race-sex group. Similar analyses were used to explore the association of cancer mortality 
with the self-reported use of DDT. 
SerumDDE 
The distribution of serum DDE was examined among the 898 participants and 
divided into tertiles, quartiles and quintiles. There was only one subject with a trace level 
of DDE; a value of 0.5 ppb was assigned for the purpose of statistical analyses for that 
subject. Cutpoints ofDDE tertiles, quartiles and quintiles were determined using 
frequency tables for the combined study sample, for the gender specific groups and race-
gender specific groups. 
Descriptive Statistics 
The putative risk variables measured in 1974/75 were examined univariately to 
determine if they were risk factors for cancer mortality and/or associated with DDE, using 
both the reported use data and actual serum measurements. The putative risk factors 
included age (measured in years), education (measured in years), BMI (measured in 
kg/m2 ), cholesterol (measured in mgldl), race (categorized as white, black or high SES 
black), gender (male or female) and smoking status (current or not). 
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There were 27 subjects who had missing BMI values and 9 who had missing 
cholesterol levels. Averages from previous examinations were substituted for these 
missing data. DDE levels and all covariates pertained to 1974/75 and were not re-
evaluated during the follow-up period. Measurements were available on 898 subjects out 
of the 1434 who participated in Phase VII; those with DDT measurements were slightly 
younger (59.9 vs. 62.1 years), more likely to be male (75 vs. 50 %), more likely to be 
white (70 vs. 50 %) and had slightly higher levels of education (9.8 vs. 8.3 years) as 
compared to participants for whom no blood specimens were obtained. There was no 
difference in average cholesterol values and the percentage who reported current smoking 
between those who provided blood samples and those who did not. 
The putative risk factors were compared across tertiles ofDDE for both the entire 
cohort and separately for men and women (using gender specific cutpoints) to determine 
the level of association. Additional models were constructed for adjustment of age, 
gender and race. The ordinal trend test across DDE values was performed for categorical 
variables using logistic regression and for the continuous variables with a linear 
regression test. These models for trend included DDE as an ordinal variable representing 
the tertile level as the independent measure while the putative risk variable was the 
dependent measure. 
Frequency tables were also constructed for each of these variables to determine 
their association with cancer status. All comparisons for the categorical variables were 
made using a chi-square test. If a 2x2 table had a cell count less than 5, then the p-value 
from Fisher's Exact test was used. Student's t-tests were used to compare the mean 
differences in the continuous variables for the two groups of subjects: those who died of 
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cancer versus the remaining cohort. Additionally, tests to determine the association of 
each risk factor with cancer mortality were constructed adjusting for age, gender and race 
using logistic regression. 
Standardized Mortality Ratio 
Standardized Mortality Ratios (SMR) were computed using the United States 
population as the external comparison group. The expected death rates were provided by 
the Center for Disease Control and Prevention (1979-1994; on-line 
http://wonder.cdc.gov) and National Cancer Institute (1974-1978; 1987 Annual Cancer 
Statistic Review) databases (CDC, 1997; NCI, 1987). The cancer mortality was defined 
by ICD9 codes 140-239 (excluding the benign neoplasms). The expected rates were 
stratified by age groups (35-44, 45-54, 55-64, 65-74, 75-84, >85) and by year (1974-79, 
1980-84, 1985-89, 1990-94). Rates were constructed for age, calendar year and DDE 
tertiles; and all combinations of these. 
The observed number of deaths and person-years in this cohort was computed for 
each age, calendar year and/or DDE tertile. The person-years of observation for each 
subject was calculated as the length of time between entry into the study and time of 
death or censoring date (December 31, 1994). Crude rates were calculated by dividing 
the observed number of deaths by the number of person-years within each strata and 
recorded per 100,000 person-years. The expected number of deaths was computed by 
multiplying the expected death rate (obtained from the mentioned databases) by the 
person-years observed in each category (age, year, DDE tertile). The SMR was obtained 
by dividing the total number of observed deaths by the sum of the expected deaths. 
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Because there was no standardized database for nnE measurements, the expected death 
rate was assumed to remain constant across the tertiles of nnE. The marginal totals for 
the tertiles estimated the SMR adjusted for age group and calendar year. These values 
were then used to produce a summary table. (Appendix C contains the entire set of data 
generated for the SMR.) Relative risks and their 95% confidence intervals were 
estimated using maximum likelihood estimation procedures. Tests for homogeneity and 
trend were calculated also using these estimation procedures (Breslow & Day, 1987). 
Poisson Regression 
The rates calculated for the SMR were assumed to have a Poisson distribution. 
Poisson regression models were constructed using the SAS® Procedure GENMOD. The 
coefficients and standard error resulting from the model were used to generate estimates 
of relative risk for cancer mortality. The outcome measure in Poisson regression was a 
rate derived from the total number of cancer deaths observed in the cohort, as the 
numerator, and the expected number of deaths as the denominator. The regression model 
was repeated using an internal comparison by substituting the observed person years for 
the denominator (Breslow & Day, 1987). The antilogarithm of the coefficient was used 
to estimate the RR. 
Survival Analysis 
Survival analysis using Cox proportional hazard regression was used to estimate 
the relative risk using SAS® PHREG. As discussed previously, this method allowed for 
adjustment of covariates and incorporated the length of follow-up. DDE was included in 
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the models as a categorical variable in the form of tertiles, quartiles, and quintiles. 
Models were constructed including both self-reported use of pesticides and history of 
DDT use. The length of follow-up was determined as the interval between either the date 
of death or the end of study for each subject and the date of the phase VII visit. Cancer 
mortality was the outcome measure. Models using the combined, gender specific and 
race-gender cutpoints were constructed. Proportionality of the hazard rates were verified 
in the manner previously discussed. 
In this study, the purpose of model selection was not to determine the best fit of 
the model but rather to explain the relationship of DDE and cancer mortality adjusting for 
known risk factors. One model adjusted for age only and another model labeled as the 
fully adjusted model included the other six covariates. Site specific analyses with models 
for lung, digestive, lymphatic and leukemia, and hormone-related cancers were also 
performed to determine if these particular cancers were associated with DOE. 
Survival analyses were also completed where ODE was included in the model as a 
continuous variable. The association beyond linearity was checked with polynomial 
regression, including a variable for linear, quadratic and cubic relationships. To avoid 
multicolinearity problems, the data were centered by subtracting the group mean from the 
individual ODE value. Tnree models were constructed: the first model included a term for 
linear association (DOE); the second model included the linear variable and added a 
quadratic term (DOE + ODE2) ; the third model included the linear term, quadratic term 
and cubic term (DOE + DDE2 + DDE3) shown below. 
Y=Po+ f31X+ P2X2+ P3 X3 
48 
This model represented a third order model with one independent variable, DDE. Note 
again, the independent variables were expressed as deviations around the mean, since X, 
X2, and X3 are often highly correlated (Neter et al., 1989). 
Survival analyses were done using combined cutpoints, gender specific cutpoints 
and race specific cutpoints. The coefficients for the model and the p-value for 
significance were recorded. This analysis was repeated with adjustment for covariates. 
Reported Use versus Measured Levels 
The self-reported use of pesticides was compared to the actual levels ofp,p'DDE 
measured at the time of the interview. Mean levels ofDDE and the standard deviations 
were calculated for the cohort and compared for self-reported use. These measures were 
stratified by race and gender. Student's t-tests compared the mean differences for those 
who reported use compared to those who did not. 
Specific Aim 3 
To test the hypothesis that an increased risk of breast and prostate cancer are 
associated with increasing levels ofDDE. 
Nested Case-Control Design 
Whereas the previous specific aims investigated the risk ofDDE levels associated 
with cancer mortality, this specific aim addressed cancer incidence. The particular 
outcomes evaluated were breast cancer in women and prostate cancer in men. A nested 
case-control approach was used in which the subjects were selected from those 898 
participants who had DDT measurements made in 1974/75, and who were followed 
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prospectively over the next twenty years. Eight women had diagnosed breast cancer and 
two men had diagnosed prostate cancer before the time of DDT measurement in 1974/75 
and were not included in the statistical analyses. Thus, 395 women and 493 men who 
supplied a serum sample, and who also had a negative history of cancer at the 1974/75 
examination, made up the pool of subjects available for the nested case control study. 
Cohort members who developed breast or prostate cancer were included as cases 
in the matched design. Four control subjects were matched to each case. Control 
subjects were selected at random from risk sets consisting of all cohort members who 
were free of cancer and who matched the case patient on race and age (± 3 years). In one 
case, there was an insufficient number of cases within the three year age range from 
which to draw and the range was extended. 
SerumDDE 
Comparisons ofDDE levels in case patients and their controls were made by 
matched analysis using t-tests. The distribution of serum DDE was examined and divided 
into tertiles. Estimated relative risk, the odds ratio (OR), was determined by conditional 
multiple logistic regression with DDE included in the model as the exposure variable. 
Regression models were evaluated with DDE expressed in tertiles and also in a 
continuous form. The relationship between serum ODE with breast cancer and prostate 
cancer was adjusted for covariates collected in 1974 or prior. Particular covariates were 
chosen because they had been identified as risk factors in other studies. Multivariate 
analyses were performed with SAS® PHREG procedure. 
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Descriptive Statistics 
The putative risk variables measured in 1974/75 were examined univariately to 
determine if they were a risk factor for cancer mortality and/or associated with DOE. The 
variables included age (measured in years), education (measured in years), BMI 
(measured in kglm2), cholesterol (measured in mg/dl), race (white, black or high SES 
black), gender (male or female) and smoking (current or not). As described in a previous 
section, the potential risk variables for breast cancer were collected in the 1994/95 
follow-up. These included nulliparous status (never pregnant or have had at least one 
pregnancy), lactation history (have breast fed, never breast fed, or unknown), positive 
family history of breast cancer (mother, sister or daughter had breast cancer, or mother, 
sister, and daughter did not, or unknown status), and age at first full term pregnancy ( 30 
years or greater, < 30 years, or unknown status). 
The putative risk factors were compared across tertiles ofDDE. The test for linear 
trend across DDE values was computed for categorical variables using logistic regression 
and for the continuous variables using linear regression. These models included DDE 
coded as an ordinal variable to represent the tertile level as the independent measure and 
each risk factor as the dependent measure. 
Frequency tables were also constructed for each of these variables to test their 
association with cancer incidence. All comparisons for the categorical variables were 
made using a chi-square test. If a 2x2 table had a cell count less than 5, then the p-value 
from Fisher's Exact test was used. For comparisons involving continuous variables, 
Student's t-tests were used to compare the mean differences for those with cancer to those 
without. Matched analysis was performed by comparing the case patient to hislher four 
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age and race matched controls. The tests which involved continuous variables were 
constructed by creating a variable to obtain the difference of the selected risk factor for 
the case subject and each of the four matched controls. A simple one sample t-test was 
performed to determine if this score differed from zero. For categorical risk factors, a 
chi-square statistic with one degree of freedom was calculated to test the association 
between the case and matched controls. This statistic was computed by creating a 
frequency table obtaining the marginal totals of the selected variable. The formula used 









2 = [fm - 1) X++ - m(X++ - X+l) ]2 
m X++ - IXi+2 
where n = number of cases; 
m = 1 + number of controls; 
J=m 
I = 1, 2, ... n 
J = 1, 2, ... m 
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Conditional Logistic Regression 
Conditional logistic regression models were constructed to examine the estimated 
risk for breast cancer in women and prostate cancer in men. Conditional maximum 
likelihood estimation was used because of the matched case-control design. 
Unconditional estimation would require the model to be invariably large due to the 
number of dummy variables required to reflect the matching strata. Furthermore, the 
conditional approach gives unbiased estimates in this setting. Modeling matched data 
requires the matched set to be considered in strata (Kleinbaum, 1991). The strata were 
determined by the age and race matched sets. Among breast cancers, there were 105 
persons in 21 matched sets, or strata. Each strata contained 5 persons, one of whom was 
a case and the other 4 were the matched controls. In the prostate cancer design, there were 
112 persons in 28 matched sets. 
Multivariable matched conditional logistic regression analyses, which permitted 
adjusting of covariates not used as matching criteria, were conducted with the PHREG 
procedure in SAS®. The likelihood maximized by PROC PHREG was made identical to 
the likelihood for the conditional logistic regression through modification of the data set. 
For the 1:4 matched data, the likelihood for conditional logistic regression reduced to that 
of the Cox model for the continuous time scale. This conditional logistic regression was a 
stratified analysis, where each matched set was a stratum. A time variable was created so 
that all cases in a matched set or stratum had the same event time value and so the 
corresponding controls were censored at later times. The steps taken to perform this 
analysis are briefly described here (SAS, 1995). 
• First, age and race strata were formed for eac~ matched set. For breast cancer there 
were 21 matched sets and for prostate cancer there were 28 matched sets. 
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• Two variables were specified on the left side of the equality in the Cox model 
statement: a variable that contained a time of occurrence of an event (STATUS) and 
a variable that indicated whether or not the observation was censored (FNDX). 
• STATUS was simply a dummy variable, constructed so that the time of the event for 
cases was less than that for all controls in the same stratum. STATUS was defined to 
be equal to 1 for the cases and as 2 for the controls. 
• FNDX was the variable used to indicate whether a subject was a case (FNOX=l) or 
control (FNDX=O). The statement, FNDX(O), cause PROC PHREG to treat the 
controls as censored. 
Example of a model to determine if cancer was associated with DDE adjusting for 
education, matched on age and race as previously described, is shown below. 
Model STATUS*FNDX(O) = DDE education. 
Power 
The nested case control study of breast and prostate cancer used matching to 
control for race and age. This study design was chosen so that comparisons of our work 
with previously published studies: for example, Wolff et a1. and Krieger et a1. could be 
made more easily. However this study design made it difficult to calculate the statistical 
power, and three approaches were considered. To calculate power in a matched design 
with multiple controls per case, and where the exposure level was not dichotomous would 
require solving a system of non-linear equations (Breslow & Day, 1980). Thus, this 
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approach was not feasible. The second approach where Breslow and Day reported 
solutions for sample size and power under the conditions of 1 :M matching with a 
dichotomous exposure was considered. This technique where the exposure was 
categorized into tertiles, would require a comparison of tertile 1 vs 2 and tertile 1 vs 3. In 
the process of creating dichotomous groupings, some of the subjects were necessarily 
eliminated. For example, comparing those in the highest tertile to those in the lowest 
would eliminate the subjects in the middle tertile.. Furthermore, because cases and 
controls would often be in different tertiles, it created a mUltiple control atmosphere and 
complicated the situation. However, if the latter problem was ignored, a 1:4 matching for 
a dichotomous exposure yielded a power of 80 % to detect an OR of at least 4.5 for either 
breast or prostate cancer when 30 % of the population was considered to be exposed. 
A third approach was considered in which the statistical power of the study was 
estimated using an unequal case-control ratio in an unmatched setting (Schlesselman, 
1982). The formula used for this analysis is presented as: 
Zp = [n (PI - PO)2 I ( 1 + lie) p' q' ]112 - Za. 
where, 
Po =exposured rate among controls in the target population 
c = number of controls per case = 4 
n = number of cases 
PI= (Po R) I (1 + (Po - R)) 
p' = (P 1 + cpo) I (1 + c) 
q' = 1 - p' 
The power was calculated as: 
Power = P(Z < Zp ) 
The following sections present the power of the analyses for a range of risk estimates, 
assuming that 30 % of the population was exposed to high levels of DDT and 
a = 0.05 
Breast Cancer 
In the Charleston cohort, there were 21 breast cancer cases identified over the twenty-
year period and these were matched to 4 controls by race and age which totaled 84 
controls. 
Table 9 

















In the Charleston cohort, there were 28 prostate cancer cases identified over the twenty-
year period and these were matched to 4 controls by race and age which totaled 112 
controls. 
Table 10 

















A meta-analysis of the case-control studies of breast cancer and DDE/published to 
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date thus far was performed. The ratio of mean concentrations was used as theeffec\ 
measure. For each study the delta method was used to determine the variance of the log 
of the ratio of mean concentrations. This formula was derived as: 
For case-control studies, the summary ratios of the mean concentrations ofDDE 
between cases and controls were derived from the weighted averages of the logarithm of 
the ratios from the individual studies. Weights were taken to be proportional to the 
inverse variance of the log ratios of the mean concentrations. The variance of the 
summary measure was taken to be the inverse of the sum of the weights (Adami et al., 
1995). 
IV. Results 
Specific Aim 1 
To describe the cancer mortality patterns with reference to environmental factors 




d. tobacco use 
e. water supply 
f. physical activity 
Vital Statistics and Cancer Mortality 
Table 11 gives the vital status of the Charleston Heart Study (CHS) from baseline 
through December 31, 1994. During the thirty-four year follow-up over half of the cohort 
died, yielding a total of 1463 deaths. More deaths occurred among men than women with a 
greater proportionate mortality in black men and women. Four hundred sixty-three (71 %) of 
the white men died, 251 (75 %) of black men died and 46 (45 %) of the high SES black men 
died. Among the white women there were 403 deaths and among the black women there 
were 300 deaths which accounted for 54 %, and 66 % in the race-gender groups respectively. 
There were 294 cancer deaths observed over the thirty-four year follow-up period: 
1960-1994. Overall, these accounted for 20 percent of all deaths. Among white men, 104 of 
the 463 (16 %) deaths were due to cancer. Similarly, the proportion of deaths due to cancer 
were 18% (46/251) for black men, 26 % (12/46) for high SES black men, 21 % (86/403) for 
white women and 15 % (46/300) for black women. 
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Table 11 
Vital Statistics for Charleston Heart Study 
1960-1994 
All Cancer 
N Deaths Deaths Alive Unknown 
White Men 653 463 104 175 15 
Black Men 333 251 46 77 5 
High SES Black Men* 102 46 12 55 _1 
1088 760 162 307 21 
White Women 741 403 86 318 20 
Black Women 454 300 46 143 11 
1195 703 132 461 31 
Total 2283 1463 294 768 52 
*Recruited in the 1963 recall 
The distribution of cancer deaths by anatomical site is listed in Table 12. Because of 
the small number of deaths for some cancer sites, groupings were created from the 
International Classification of Diseases (leD) codes. Lung cancer occurred with the highest 
frequency overall as well as for the men. It was the second most frequent type of cancer 
among the women. Digestive tract cancers which included esophagus, colon, small intestine, 
rectum, liver, stomach, gall bladder, and pancreas accounted for more of the cancer deaths for 
the women than any of the other types. There were 37 digestive cancer deaths for both men 
and women, making this the most frequent type in the women and the second most frequent 
type in the men. There were 21 prostate cancer deaths and 21 breast cancer deaths, with only 
one breast cancer occurring in the men. 
Table 12 
Frequency of Cancer Deaths (1960-1994) by Site 
Cancer Site (ICD Code*) Total Deaths 
Digestive System (150-159) 
Respiratory System (160-165) 
Breast (174) 




Brain & Nervous System (191,192) 
Lymphatic System (200-203) 
Leukemia (204-207) 
Other (141,148,149,171,172) 
















* International Classification of Diseases, Revision 8 and 9 





























Descriptive statistics for the environmental risk factors measured in 1960/63 were 
obtained. Table 13 shows univariate comparisons of these potential risk factors for those 
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who subsequently died of cancer causes versus those not dying or dying of other causes. The 
statistical significance (p-value) presented in the table was determined from two methods: 
the unadjusted value from pooled t-tests or chi-square analysis and the adjusted value from 
logistic regression models which included age, gender and race. There was a borderline 
statistically significant difference for age. The average age at baseline was 50.8 for those 
who died of cancer during the follow-up while the average age was 49.7 for those not dying 
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of cancer. More men died from cancer than women. There was little difference in the 
proportion of cancer deaths between the two race groups. Because cancer mortality has been 
shown to be associated with age, race and gender in other studies, the environmental risk 
factors (occupation, physical activity, smoking, residence and water supply) were all adjusted 
for age, race and gender. For each occupation, the association with cancer mortality was 
evaluated relative to all other occupations. There was a statistically significant association of 
cancer mortality status with two of the occupational groups, laborer and housewives. Having 
an occupation of a non-farm lahorer compared to all other occupations was significantly 
associated with cancer mortality. Almost 48 % of those who died of cancer had been non-
farm laborers compared to 40.9 % of those who did not die of cancer. Also among those who 
did not die of cancer, there were 28.8 % who reported their occupation as housewife, whereas 
among those who died of cancer there were 21.3 % who were housewives. No other 
occupational group was significantly associated with cancer mortality status. There was also 
no statistically significant association observed between educational status and cancer 
mortality. For the physical activity category, both the current level and the level 10 years 
earlier more subjects reported a light activity level followed by medium and then heavy 
activity levels. There was no statistical association for the level of reported physical fitness 
and cancer mortality status. Current. cigarette smoking was found to be a risk factor for 
cancer mortality in this cohort. The association persisted after adjustment for age, race and 
gender (p < 0.01). Among those who died of cancer, 66.7 % were current smokers while of 
those not dying of cancer 53.8 % were smokers. Before adjustment of the covariates, there 
was also suggestion of an association between cancer mortality and residence; however, this 
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Table 13 
Environmental Risk Factors and Cancer Mortality 
Cancer Deaths Unadjusted Adjusted 
Variable Yes No n-value8 I!-valueb 
Age (mean, years) 50.8 49.7 0.064 
Race (%, white) 64.6 60.5 0.195 
Sex (%, male) 55.1 46.6 0.006 
OccupationC (%) 
Farmer (% yes vs all others) 3.2 4.1 0.462 0.458 
Managers & Sales 19.5 17.7 0.462 0.849 
Laborers 47.8 40.9 0.028 0.059 
Military 1.8 2.2 0.635 0.355 
Professional 6.4 6.3 0.942 0.909 
Housewife 21.3 28.8 0.008 0.097 
Education (%) 0.174 0.349 
Less than high school 47.4 44.5 
Up to high school 31.1 35.7 
Up to college 16.7 13.5 
Advanced 4.8 6.3 
Reported Physical Activityd (%) 
Ten years prior to 1963 recall: 0.583 0.900 
Light 53.8 52.0 
Medium 32.2 36.1 
Heavy 14.1 12.0 
In 1963 at recall: 0.627 0.336 
Light 68.5 70.5 
Medium 24.2 24.1 
Heavy 7.4 5.4 
Smoking (%, Yes) 66.7 53.8 0.001 0.001 
Residencec 
Resided from age 20-65 (%, Urban) 85.1 89.3 0.077 0.135 
Resided first 20 years (%, Urban) 53.9 55.5 0.644 0.941 
Water Supply (%, City)d 76.5 72.7 0.333 0.258 
ap-value derived from pooled t-test or chi-square analyses 
b Adjusted for age at baseline, race and sex 
cHigh Socioeconomic Men Missing 
d 1963 Recall only 
difference diminished upon adjustment for age, race and gender. There was also no 
statistically significant association observed among water supply and subsequent cancer 
mortality. 
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Analyses to detennine whether the presence of these environmental factors increased 
the risk for cancer mortality were perfonned using Cox proportional hazards regression 
models. Table 14 gives the RR estimated from the model with each variable adjusted for age, 
race and sex. For all subjects collectively, there was no increased risk of cancer mortality 
associated with any of the occupational groups. There was also no increased risk of cancer 
mortality observed for those with a high school or higher education compared to those 
without completing high school. Reporting a medium or higher level of current physical 
activity at the time of the exam or ten years prior also showed no association with cancer 
mortality. Smoking was the only variable associated with an increased the risk for cancer in 
this cohort. The risk of cancer for current smokers compared to non-smokers was almost 
doubled. There was a suggestion of an increased risk for cancer mortality for rural residency 
during the ages of 20-65; however, the upper confidence interval included 1.00. Those with 
city water had an increased risk for cancer mortality; however, this risk was not statistically 
significant. Multivariable models, not shown in Table 14, were constructed to detennine if 
adjustment for all the factors would modify the relative risks. Smoking was found to be the 
only statistically significant factor in the multivariable models. 
The Cox proportional hazards regression was repeated for men and women separately. 
The results for the gender specific analysis are also given in Table 14. The only difference in 
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the gender specific models that was not observed in the entire cohort collectively occurred for 
the occupational 
Table 14 
Relative Risks of Cancer Mortality from Selected Environmental Risk Factors 
RR ( 95 % Confidence Intervals) 








0.75 (0.38, 1.49) 
0.79(0.56,1.12) 
0.84 (0.52, 1.36) 
0.96 (0.69, 1.34) 
1.30 (0.98, 1.75) 
1.04 (0.42, 2.56) 
Education 1.05 (0.77,1.44) 
High School and above 
Physical Activity (10 yrs) 0.93 (0.70, 1.30) 
Medium and Heavy 
Physical Activity (current) 0.96 (0.69, 1.42) 
Medium and Heavy 
Smoking 1.73 (1.36, 2.20) 
Current smoker 
Residence(20-65 years) 0.72 (0.54, 1.00) 
Urban 
Residence «20 years) 1.06 (0.88, 1.27) 
Urban 
Water Supply 1.39 (0.93, 2.06) 
City 
0.82 (0.33, 2.03) 
0.73 (0.37, 1.45) 
0.78 (0.52, 1.18) 
1.48 (1.03, 2.12) 
0.68 (0.28, 1.68) 
1.02 (0.68, 1.54) 
1.14 (0.85, 1.53) 
1.13 (0.82, 1.55) 
1.86 (1.32, 2.63) 
0.78 (0.54, 1.13) 
1.11 (0.87, 1.41) 
1.42 (0.83, 2.45) 
aRR derived from Cox regression models adjusted for age, race and gender 
bRR derived from Cox regression models adjusted for age and race 
0.70 (0.25, 1.96) 
0.79 (0.55,1.13) 
1.00 (0.51, 1.98) 
1.23 (0.78, 1.96) 
1.35 (0.84, 2.02) 
1.09 (0.67, 1.78) 
0.74 (0.47, 1.16) 
0.76 (0.45, 1.31) 
1.65 (1.16,2.34) 
0.74 (0.50, 1.09) 
1.00 (0.76, 1.30) 
1.32 (0.75, 2.43) 
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category of the non-fann laborers. The RR for men was 1.48 (el: 1.03,2.12) suggesting an 
increased risk for cancer mortality for those men employed as non-farm laborers. Smoking 
was found to be a risk factor for cancer mortality for both men and women. All other 
environmental factors did not indicate an increased risk of cancer mortality for the men or 
women. 
Specific Aim 2 
To quantify the association between pesticide exposure and cancer mortality using: 
a. self-reported use of pesticides 
b. serum DDE levels 
and to compare the utility of self-reported use of pesticides. 
Vital Statistics and Cancer Mortality 
Among the 898 subjects who had serum levels ofDDE quantified in 1974/75, a total 
of 438 (49 %) deaths occurred over the twenty-year follow-up period. The average length of 
time in the study before cancer death was 16 years and ranged from 1 to 20 years. Overall, 
there were 108 deaths (25%) attributed to cancer, as noted in Table 15. Among white men, 
there were 179 (60 %) deaths of which 42 (24 %) were due to cancer; black men contributed 
81 (63 %) deaths with 21 (23 %) of these deaths due to cancer, and for the high SES black 
men there were 26 (39 %) total deaths with 6 (23 %) cancer deaths. Among white women, 
there were 114 (36 %) deaths and 29 (25 %) of these deaths due to cancer. Black women 
had 38 total deaths (45 %) with 10 (26 %) deaths due to cancer. 
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Table 15 
Vital Statistics for Charleston Heart Study* 
1974175-1994 
All Cancer 
N Deaths Deaths Alive 
White Men 300 179 42 121 
Black Men 129 81 21 48 
High SES Black Men 66 26 § 40 
495 286 69 209 
White Women 319 114 29 205 
Black Women 84 38 10 46 
403 152 39 251 
Total 898 438 108 460 
*Includes only subjects who had serum DDE measured in 1974/75 
Lung cancer was the most frequent cancer site observed among both men and women, 
as noted in Table 16. Lung cancer accounted for 9 % of all deaths and 36 % of all cancer 
deaths. The second most frequent cancer site was the digestive tract which included cancer 
of the esophagus, stomach, colon, gall bladder and pancreas. These cancers accounted for 6 
% of all deaths and 25 % of all cancer deaths. There were 5 leukemia deaths and 4 lymphatic 
cancer deaths, both groups together accounted for about 2 % of all deaths and 8 % of all 
cancer deaths. There were 17 hormone-related cancers with 8 prostate, 7 breast, 1 ovarian 
and 1 uterine. Taken together, the honnone-related cancers accounted for about 4 % of all 
deaths and 16 % of cancer deaths. 
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Table 16 
Distribution of Cancer Deaths by Site 
Cancer Site Total Deaths Men Women 
Lung (162) 39 26 13 
Digestive (150-159) 25 17 8 
Lymphatic & Leukemia (200-208) 9 5 4 
Honnone-Related (174,179,183,185) 17 9 8 
Other * 18 12 6 
Total 108 69 39 
* Two or fewer deaths per site 
The standardized mortality ratio, SMR, was computed with the U.S. population as the 
external comparison group. The SMR was used to detennine whether the CHS cohort 
experienced the same cancer mortality pattern as the standard population. Because the eRS 
had higher levels ofDDE, as reported in a previous section, there was concern that a bias 
may have been introduced which would obscure any increased risk of cancer mortality 
associated with high exposure levels. The SMR addressed this concern by providing an 
external comparison. This estimate was adjusted for age in groups of five years beginning 
with age 35 ( 35-39, 40-44, 45-49, 50 .. 54, 55-59, 60-64, 65-69, 70-74, 75-79, ::s..80) and also 
for calendar year in five-year intervals beginning with 1974 (1974-1979, 1980-1984, 1985-
1989, 1990-1994). The expected and observed rates are included in Appendix C. 
Although there was a slight increase in the number of total cancer deaths for this 
cohort compared to that expected in the U.S., the difference was not statistically significant. 
The SMR adjusted for age and calendar year was 1.07 (95% CI: 0.97, 1.16). 
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Frequency of Reported Use 
The analyses of self-reported data, were restricted to those for whom DDT 
measurements were made in 1974/75. The frequency of self-reported use of pesticides for 
each race-sex group is in Table 17. The first half of the table shows the frequency of those 
who reported ever using pesticides. There were 258 (29 %) participants who reported not 
ever using pesticides and 638 (71 %) who reported some use. There was a statistically 
Table 17 
Frequency Table of Reported Use of Pesticide Stratified By Race-Sex Group 
R S G ace- ex roup 
Reported White White Black Black High SES 
Pesticide U se* Men Women Men Women Black Men Total 
No 73 83 50 24 28 258 
Yes 227 234 79 60 38 638 
Total 300 317 129 84 66 896 
. . ~- -* Answered yes to any of the three pestIcIde questIons X -16.2, p=0.003 
Ra S G ce- ex roup 
Reported White White Black Black High SES 
DDTUse* Men Women Men Women Black Men Total 
No 91 37 14 5 3 152 
Yes 203 276 100 79 54 712 
Total 294 313 114 84 57 864 
ered es to the *Answ y q uestion re ardin g ex osure to DDT g p ~=62.3 -,p 0.001 
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significant difference in reported pesticide use by race and gender. The most frequent users 
of pesticides were the white men with 227 (76%) giving a positive response. The second 
most frequent users were white women with 234 (74 %) reporting pesticide use. Black 
subj ects reported slightly less use, and the high SES black reported the lowest use, with 38 
out of 66 (58 %). 
The second half of the table shows the self reported use of DDT. There was a 
statistically significant difference in DDT use by race and gender. There were 152 
(18 %) who reported an experience of DDT exposure, while a much larger group, 712 
(82 %), reported no exposure to DDT. Among the white men, 93 (31 %) reported using 
DDT, while 37 (13 %) white women, 14 (12 %) black men,S (6 %) black women and 3 
(5 %) of the high SES black men reported specific DDT use. 
Confounding: Reported Use and Cancer Mortality 
To investigate the potential existence of confounding variables, univariate descriptive 
statistics for selected variables were examined across the exposure levels. The variables 
chosen were putative cancer risk factors for which data were available in the cohort. 
Table 18 contains the comparison of these potential confounding variables by self-
reported pesticide usage. The statistical significance was determined from two methods: one 
was based on the unadjusted value from pooled t-tests or chi-square analysis, and the second 
was from logistic regression models adjusting for age, gender and sex. The risk factors 
which were statistically significant between exposure groups were race and education; with 
more whites reporting use compared to blacks and more pesticide use associated with higher 
education. After adjusting for age, race and gender, however, the p-value for education 
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increased to 0.25, becoming non-statistically significant. There was marginal significance for 
smoking in the unadjusted case which became non-significant after adjustment. Also, after 
adjustment for age, race and gender, BMI became borderline statistically significant with a p-
value of 0.06. This suggested a larger BMI was associated with reporting of pesticide usage. 
There was no difference among the exposure groups for cholesterol levels. 
Table 18 
Comparison of Putative Risk Factors with Reported Use of Pesticides 
Age (mean years) 
Gender (% male) 
Race (% white) 
Smoking (% smokers) 
Education (mean years) 
BMI (mean kg/m2) 

















a p-value derived from pooled t-test or chi-square analysis 














These same potential covariates were also tested to determine if they were associated 
with an increased risk for cancer. Table 19 indicated an increasing age, male sex and 
cigarette smoking as risk factors for cancer mortality in this cohort with serum DDT 
measurements. After adjusting for age, race and gender, smoking retained its statistical 
significance. Both education and body mass index were not found to be significant risk 
factors for this cohort, either before or after adjustment. Cholesterol reached borderline 
statistical significance before adjustment of the covariates and the p-value decreased further 
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after adjustment. This suggested that those with lower cholesterol had an increased risk for 
cancer. Thus, based upon the results in Tables 18 and 19, race was the only variable found to 
be a confounder between reported pesticide use and cancer mortality in this cohort. 
Table 19 
Cancer Deaths and Possible Risk Factors 
For Subjects with DDT Measurements 
Age (mean years) 
Gender (% male) 
Race (% white) 
Smoking (% smokers) 
Education (mean years) 
BMI (mean kglm2) 

















a p-value derived from pooled t-test or chi-square analysis 
b Adjusted for age, race and gender 














Of those who died of cancer, 26% answered "no" to all three questions concerning 
pesticide use while 74% answered "yes" to at least one question, as noted in the top portion 
of Table 20. Overall, 638 (71 %) subjects reported some use of pesticides. The crude RR, 
was 1.14, suggesting a 14 % increased risk of cancer associated with reported use of 
pesticides. The latter part of Table 20 gives the results obtained from the question regarding 
DDT exposure. Overall, only 152 (17 %) answered "yes" to the question regarding DDT 
and of those dying of cancer, 20 (19 %) replied "yes" and 85 (80 %) replied "no". The crude 
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RR for this data was 1.10, also suggesting a slight increased risk of cancer mortality 
associated with a reported history of DDT. 
Table 20 
Self-Reported Use of Pesticide and Cancer Mortality 
Cancer Death 
Reported 
Pesticide U se* No Yes Total 
No 230 28 258 
Yes 559 79 638 
Total 789 107 896 
RR = 1.14 
* Answered yes to any of the three pesticide questions 
Cancer Death 
Reported 
DDTUse* No Yes Total 
No 627 85 712 
Yes 132 20 152 
Total 759 105 864 
RR = 1.10 
* Answered yes to the question regarding exposure to DDT 
Table 21 contains the results from several Cox proportional hazards (PH) regression 
models with reported pesticide use defined as yes to any of the three questions. Models were 
constructed for the total sample and also stratified by gender. Some models adjusted only for 
the effect of race, which was found to be a confounder, and other models adjusted for the 
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additional factors of age, smoking, BMI, education and cholesterol. The first model adjusted 
for race only and yielded a non-statistically significant RR of 1.10 (CI: 0.72, 1.70); adding 
Table 21 






























1.10 (0.72, 1.70) 
RRa (9S% CI) 
1.00 
1.34 (0.76, 2.36) 
RRa (95% CI) 
1.00 
0.78 (0.40, I.S4) 
* Answered yes to any question regarding pesticide use in 1974/75 
a Adjusted for race 
b Adjusted for age, smoking, race, gender, BMI, cholesterol, education 
C Adjusted for age, smoking, race, BMI, cholesterol, education 
RRb (9S% CI) 
1.00 
1.25 (0.80, 1.9S) 
RRC(95% CI) 
1.00 
1.54 (0.86, 2.75) 
RRC(95% CI) 
1.00 
0.75 (0.37, 1.50) 
other risk variables slightly increased the estimate of the relative risk to 1.25 (CI: 0.80, 1.95). 
For gender specific models, men showed over a 30 % increased risk of cancer mortality for 
past pesticide use compared to those reporting no use. However, the increased risk was not 
statistically significant (RR= 1.34, CI: 0.76, 2.36). For women there was no association of 
cancer mortality with DDT using the self-reported data for either model. 
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Table 22 gives the results from Cox PH Regression with the exposure defined as self-
reported DDT use. The RR was 1.09 eCI: 0.66,1.74) for the model adjusting for age only and 
decreased in the fully adjusted model, thus suggesting no association of reported use of DDT 
and cancer mortality. In the gender specific analyses, there were 17 men who died of cancer 
and reported a positive use of DDT and 50 men who died of cancer and reported no use of 
DDT. The risk estimates for both models were near 1.00, indicating no association. For the 
women, out of the 38 women who died of cancer, only 3 reported a positive history of DDT 
usage and the risk estimates also suggested no association of DDT usage and cancer 
mortality. 
Summary o/Self-Reported Use and Cancer Mortality 
In summary, there was no evidence to support an increased risk of cancer mortality 
with reported pesticide usage. This finding was confinned for pesticide use in general and 
for DDT specifically. Adjustment for the confounder race as well as adjustment for other 
cancer risk factors did not alter these findings. 
Table 22 
Relative Risks for All Cancer Mortality and Reported Pesticide Use* 























1.09 (0.67, 1.79) 
RRa (95% CI) 
1.00 
1.00 (0.57, 1.77) 
RRa (95% CI) 
1.00 
0.68 (0.21, 2.23) 
• Answered yes to any question regarding exposed to DDT in 1974/75 
a Adjusted for age 
b Adjusted for age, smoking, race, gender, BMI, cholesterol, education 
C Adjusted for age, smoking, race, BMI, cholesterol, education 
Mean Levels o/Serum DDE 
RRb (95% CI) 
1.00 
1.04 (0.63, 1.73) 
RRC(95% CI) 
1.00 





The mean serum level ofDDE for the 898 participants was 36.7 ppb with a standard 
deviation of 27.9 ppb. The highest levels occurred among black men, who had an average 
59.27 ppb followed by black women (47.20 ppb), white men (32.61 ppb) and white women 
(27.68 ppb). The differences in DDE levels among the four race-sex groups was statistically 
significant (p < 0.1). 
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Confounding: Serum DDE and Cancer Mortality 
Table 23 contains a comparison of putative risk factors across DDE tertile levels. As 
noted in this table DDE levels increased with age, and higher levels were noted in blacks 
compared to whites and in men compared to women. After adjusting for age, race, and 
gender, there was no linear trend for smoking status or levels ofBMI. However, those with 
higher cholesterol and lower education had higher levels ofDDE. 
Table 23 
Comparison of Putative Risk Factors by Serum DDE Tertiles 
DDE Tertiles* 
Tertilel Tertile 2 
(0.5.24) (25.39) 
Age (mean, years) 59.5 59.6 
Race (% White) 86.2 71.5 
Sex (% Male) 42.0 61.0 
Smoking (% yes) 31.7 37.3 
Cholesterol (mean, mgldl) 240.1 244.8 
Education (mean, years) 10.5 10.1 
BMI (mean, kglm2) 26.0 26.0 
* Serum p,p'DDE measured in parts per billion 
a Test for trend using logistic and linear regression 























These same covariates were compared for men and women separately and the results 
are shown in Table 24. DOE levels were increased in blacks compared to whites for both 
men and women. For women, ODE levels were increased with age and inversely related to 











(> 41) p-value8 p-valueb 
Age (mean, years) 
Race (% White) 
Smoking (0/0 yes) 
Cholesterol (mean, mg/dl) 
Education (mean, years) 
BMI (mean, kg/m2) 
Women 
Age (mean, years) 
Race (0/0 White) 
Smoking (0/0 yes) 
Cholesterol (mean, mg/dl) 
Education (mean, years) 





























a Test for trend using logistic and linear regression 





































These potential covariates were also examined to determine if they were associated 
with an increased risk for cancer mortality. Table 25 indicated male sex and an increasing 
age were found to be risk factors for cancer mortality in this cohort. After adjusting for age, 
race and gender, smoking was also a risk factor for cancer mortality, while education and 
BMI were not found to be significant risk factors. Those with lower cholesterol were at an 
increased risk for cancer mortality; however, this p-value increased after adjustment for age, 
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race and gender. (This table was similar to the findings in Table 19 which considered the 
covariates as related to cancer morality for reported usage of pesticides, instead of serwn 
measurements. Slight differences were due to the number of subjects: there were 898 subjects 
in this analysis and only 896 for the previous analysis.) 
Table 25 
Cancer Deaths and Possible Risk Factors 
Age (mean years) 
Gender (% male) 
Race (% white) 
Smoking (% smokers) 
Education (mean years) 
BMI (mean kg/m2) 

















a p-value derived from pooled t-test or chi .. square analysis 














In summary, examination of the results in from Tables 24 and 25 reveal the only 
variables as potential confounders for DDE levels and cancer mortality in this cohort to be 
age and gender. Thus, subsequent analyses were adjusted for age stratified by gender. 
Standardized Mortality Ratio 
Table 26 contains the cancer mortality rate observed over the twenty-year period 
stratified by the baseline age groups. For each of the five age groups, the number of observed 
deaths was calculated from the entire cohort and by tertile level ofDDE. No increased rate of 
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mortality was observed across DDE tertiles when examined by age strata. It is interesting to 
note that overall the higher mortality rates were observed in the middle tertile group. This 
finding was also observed in all age groups with the exception of the two youngest. 
Standardized Mortality Ratios were computed for cancer mortality by DDE tertiles, 
age group and calendar year (See Appendix D). The SMRs centered around 1.0, indicating 
no difference of cancer death rate for this cohort compared to the standard u.s. rates 
stratified for age and calendar year. Table 27 contains a summary from the SMRs for DDE 
tertiles by age group and calendar year. The SMR for the first and third tertiles were below 
1.00 (or under 100 %) while the second tertile was above 1.00. The rate ratios were 
computed using the ratio of SMRs, which will be discussed further in the next section. Both 
the test for homogeneity and trend were not statistically significant. These data do not 
provide evidence for an increasing dose-response trend of mortality with DDE category. 
TABLE 26 
Cancer Death Ratea for Charleston Heart Study 
by DDE Tertiles and AGE 
AGE Tertile 1 
1974/75 (0.5-24 ppb) 
35-44 observed 0 
person-years 41.82 
rate * 0 
45-54 observed 5 
person-years 1982.74 
rate 252.18 
55-64 observed 16 
person-years 1958.14 
rate 817.10 
65-74 observed 12 
person-years 944.06 
rate 1271.11 
75> observed 1 
person-years 180.49 
rate 554.05 
TOTAL observed 34 
person-years 5107.25 
rate 665.72 

































































Summary Table of Standardized Mortality Analysis of DDE Tertiles 
Adjusted for age and calendar year 
Tertile 1 
Number of observed deaths 34 
Person-Years 5376 
Rate( per 100,000) 632.5 
Expected deaths (adjusted for age and calendar year) 37.0 
SMR (%) 
RR (ratio of SMR) 
Test of homogeneity 





2= 3.02; p-value =0.22 
X
2
]= 2.81; p-value =0.09 
Comparison of Estimates of Relative Risks 
DDE 








A number of different statistical methods was used to obtain the relative risk of cancer 
mortality. These included the standardized mortality analysis using an external comparison 
group and Poisson and Cox Regression for the multivariable analysis. For both of the 
regression models the number of expected deaths was assumed to be unknown. Table 28 
gives a summary of the results from these methods. There were 34 cancer deaths in the 
lowest level of DDE, 41 deaths in the second tertile and 33 in the highest tertile. The first 
model, labeled as RRa , gives the estimates from Cox PH models adjusted for age only. The 
RR for those in the second tertile was 1.46 compared to those in the first tertile, whereas 
those in the third tertile had a RR of 1.05 compared to those in the first. The p-value for 
trend was not statistically significant (p=O.58). The results in the second model were 
computed from the ratio of SMRs using maximum likelihood procedures to estimate the 
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confidence intervals. The results in the third model labeled as RR c, were computed from 
Poisson regression models using person-years as the rate denominator. The final model, RR d, 
used Poisson regression where the expected values were derived from the U.S. popUlation for 
an external standard in the rate denominator. The results for all of these models suggest no 
increase in risk of cancer mortality with increasing DDE levels. Because the risk estimates 
from the various tests were similar, subsequent analyses were performed only with Cox 
proportional hazards regression. 
Table 28 
Comparison of Estimates Using Rate Standardization 

















aUsing Cox Proportional Hazard Regression adjusting for age 







C Using Poisson Regression with an internal rate denominator adjusting for age and calendar year 
dUsing Poisson Regression with an external rate denominator adjusting for age and calendar year 
DDE and Cancer Associations 
Table 29 contains the results from Cox regression models with the exposure variable 
in the form of tertiles, quartiles and quintiles. Results from all three analyses showed a slight 
increased risk for those in the middle categories and a decreased risk for those in the highest 
category levels. Interestingly, a statistically significant increased risk was observed in the 
third quartile of DDE. 
Table 29 
Relative Riska of Cancer Mortality Based on Various Categories of DDE Exposure 
Variable No. Cases 



































a Unadjusted RR derived from Cox PH Regression 
RR(CI) 
1.000 
.422 (0.902, 2.240) 
1.133 (0.702, 1.829) 
1.000 
1.228 (0.713,2.117) 
1.975 (1.181, 3.300) 
1.013 (0.567, 1.810) 
1.000 
0.933 (0.509, 1.710) 
1.326 (0.748, 2.352) 
1.408 (0.789,2.512) 
0.896 (0.476, 1.688) 
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The analysis was repeated stratified by gender and the results are shown in Tables 30a 
and 30b; again the estimates followed the same pattern with the middle groups having larger 
risk estimates than the lower and upper groups. The statistical significance shown in the third 
quartile for all subjects diminished when stratified by gender. Because of the small sample 
size for the quartile and quintile groups, and since the same patterns were observed for each 
choice of categorization, subsequent models used only tertile designations. 
83 
size for the quartile and quintile groups, and since the same patterns were observed for each 
choice of categorization, subsequent models used only tertile designations. 
Table 30a 
Relative Risk8 of Cancer Mortality Based on Various Categories of DDE Exposure 
By Gender 
Men cases ~-value RR(CI) 
Tertile DDE 
1 20 1.000 
2 30 0.13 1.546 (0.878, 2.723) 
3 19 0.93 1.027 (0.548, 1.924) 
Quartile DDE 
1 12 1.000 
2 22 0.11 1.767 (0.875, 3.571) 
3 21 0.11 1.771 (0.871, 3.600) 
4 14 0.68 1.173 (0.543, 2.537) 
Quintile DDE 
1 8 1.000 
2 15 0.11 2.001 (0.848, 4.721) 
3 21 0.02 2.660 (1.178, 6.007) 
4 13 0.20 1.737 (0.741, 4.312) 
5 12 0.36 1.516 (0.620, 3.709) 
a Unadjusted RR derived from, Cox PH Regression 
Table 30b 




1 16 1.000 
2 10 0.29 0.655 (0.297, 1.442) 
3 13 0.77 0.895 (0.430, 1.860) 
Quartile DOE 
1 8 1.000 
2 12 0.46 1.405 (0.574, 3.437) 
3 10 0.05 1.319 (1.181, 3.342) 
4 9 0.83 1.112 (0.429, 2.882) 
Quintile DOE 
1 5 1.000 
2 12 0.08 2.504 (0.882, 7.108) 
3 8 0.61 1.331 (0.435, 4.070) 
4 7 0.42 1.601 (0.508, 5.047) 
5 7 0.71 1.246 (0.395, 3.926) 
a Unadjusted RR derived from Cox PH Regression 
To examine 'Ute effect of tertile categories on the RR, analyses were conducted with 
various cutpoints used to define the tertiles. In Tables 31 a, 31 b, and 31 c, results from Cox 
models are shown for the different race-sex groups. The first part, Table 31 a, contains the 
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estimates from the entire cohort with the cutpoints of DOE determined from the entire cohort. 
The second set of analyses, Table 31 b, were performed with race-sex specific terti Ie 
cutpoints, while the last part of the table, Table 31 c, shows the results using gender specific 
cutpoints. Examination of results from all of the analyses, confirmed the lack of any trend or 
statistical association regardless of the specific tertile definition. 
Table 31a 
Relative Risk of Cancer Mortality Using Various Tertile Definitions ofDDE· 
Tertile Cutpoints derived from DDE distribution for all subjects 
All Subjects Tertile 1 
2 
3 
White Men Tertile 1 
2 
3 
White Women Tertile 1 
2 
3 
Black Men Tertile 1 
2 
3 
Black Women Tertile 1 
2 
3 





(25, 39 ) 
(> 35 ) 
(0.5, 24) 
(25, 39 ) 
( > 39) 
(0.5, 24) 
(25, 39 ) 
( > 39) 
(0.5, 24) 
(25, 39 ) 
( > 39) 
(0.5, 24) 
(25, 39 ) 
( > 39) 
(0.5, 24) 
(25, 39 ) 
( > 39) 




















Relative Risk of Cancer Mortality Using Various Tertile Definitions ofDDE* 
Tertile Cutpoints derived from DDE distribution from each race-sex group 
White Men Tertile 1 
2 
3 
White Women Tertile 1 
2 
3 
Black Men Tertile 1 
2 
3 
Black Women Tertile 1 
2 
3 





(25, 37 ) 
( > 37 ) 
(0.5, 19) 
(20, 30 ) 
( > 30) 
(0.5, 37) 
(38, 58 ) 
( > 58) 
(0.5, 33) 
(34, 47 ) 
( > 47) 
(0.5, 31) 
(32, 44 ) 
( > 44) 




















Relative Risk of Cancer Mortality Using Various Tertile Definitions ofDDE* 
Tertile Cutpoints derived from DDE distribution for gender groups 
Cutpoints RR(95% CI) 
All Men Tertile 1 (0.5,27) 1.000 
2 (28, 41 ) 1.546(0.878, 2.723) 
3 ( > 41 ) 1.076(0.579, 2.000) 
White Men Tertile 1 (0.5, 27) 1.000 
2 (28,41 ) 1.738(0.913, 3.310) 
3 ( > 41 ) 0.570(0.190, 1.704) 
Black Men Tertile 1 (0.5,27) 1.000 
2 (28,41 ) 0.849(0.202; 3.562) 
3 ( > 41 ) 1.086(0.309, 3.817) 
High SES Black Men Tertile 1 (0.5, 27) 1.000 
2 (28,41 ) 2.277(0.237, 21.891) 
3 ( > 41 ) 1.354(0.123, 14.939) 
All Women Tertile 1 (0.5, 20) 1.000 
2 (21, 34 ) 0.655(0.297, 1.442) 
3 ( > 34) 0.895(0.430, 1.860) 
White Women Tertile 1 (0.5,20) 1.000 
2 (21, 34 ) 0.663(0.278, 1.581) 
3 ( > 35 ) 0.815(0.329,2.020) 
Black Women Tertile 1 (0.5,20) 1.000 
2 (21,34 ) 0.510(0.072, 3.627) 
3 ( > 34 ) 0.739(0.149,3.671) 
* Serum DDE measured in parts per billion 
Because age and gender were the only variables that were significant risk factors for 
cancer and also associated with DDE levels, subsequent analyses controlled for their effects. 
The proportional hazards models were adjusted for age and stratified by gender. Other 
models contained additional risk variables of smoking, BMI, cholesterol and education. 
Table 32 gives the results from the two Cox models using tertile determinations based upon 
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Table 32 
Relative Risks for All Cancer Mortality 
Combined Tertiles 
cases person-years RRa (95% CI) RRb (95% CI) 
DDE Tertiles 
1 34 5107 1.00 1.00 
2 41 4392 1.46 (0.92, 2.30) 1.32 (0.82, 2.12) 
3 33 4428 1.05 (0.65, 1.70) 0.96 (0.57, 1.61) 
Gender Specific Tertiles 
Men 
cases person-years RRa(95% CI) RRC(95% CI) 
DDE Tertiles 
1 14 1981.45 1.00 1.00 
2 31 2513.80 1.534 (0.871, 2.702) 1.623 (0.908, 2.900) 
3 24 2637.97 1.041 (0.556, 1.951) 1.133 (0.573, 2.241) 
Women 
cases person-years RRa(95% CI) RRC(95% CI) 
DDE Tertiles 
1 20 3125.31 1.00 1.00 
2 10 1878.32 0.607 (0.274, 1.343) 0.564 (0.251, 1.271) 
3 9 1789.66 0.727 (0.346, 1.530) 0.629 (0.275, 1.440) 
a Adjusted for age 
b Adjusted for age, smoking, race, gender, BMI, cholesterol, education 
C Adjusted for age, smoking, race, BMI, cholesterol, education 
the distribution from the total cohort~ The first model shows the results from age-adjusted 
models while the second models show the results adjusted for additional covariates. The risk 
estimates decreased after the addition of the covariables. The RR was 1.32 (CI: 0.82, 2.12) 
for those in the second tertile compared to those in the first, while the RR was 0.96 (CI: 0.57, 
1.61) for those in the third tertile compared to those in the first. This suggested no increasing 
risk of cancer mortality associated with increasing levels of DDE. 
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The statistical analysis was repeated using the gender specific cutpoints and the 
results are shown in the bottom portion of Table 32. The risk estimates for the men in the 
first model adjusting for age only were similar to the estimates computed from the total 
cohort. There was a 50 % increase in the risk of cancer mortality for those in the second . 
tertile compared to those in the first and a 4 % increase in risk for those in the highest tertile; 
however, this trend was not statistically significant. (Recall that the same pattern existed with 
the combined group, the estimates in the highest tertile were decreased from the estimates in 
the second.) The fully adjusted model yielded slightly larger estimates than those from the 
age-adjusted model only; this was different than that found in the combined group in which 
adding other risk factors yielded smaller estimates. In summary, the results for men indicated 
no association between cancer mortality and increasing levels ofDDE. 
Among the women, there were 20 cancer deaths in the lowest levels ofDDE, 10 in 
the second tertile and 9 in the third tertile. For the model adjusting for age only, the risk 
estimates decreased in the second tertile, and there was a slight increase in the third tertile, 
For both tertile groups, the estimates were under 1.0 and the confidence intervals were 
centered around 1.0, suggesting no association between DDE levels and cancer mortality. 
The risk e~timates decreased further when additional covariates were included. 
Other analyses considered DDE as a continuous variable. Linear, quadratic and cubic 
terms for DDE were included in the Cox proportional hazard regression model to investigate 
a possible curvilinear relationship between DDE levels and cancer mortality. These results 
are shown in Table 33. The quadratic coefficient in the models was negative; thus suggesting 
an inverted u-shape relationship between DDE and cancer mortality. This finding was 
Table 33 
Cox Proportional Hazards Regressiona Coefficients 
















Linear 0.017966 0.1768 
Quadratic -0.000463 0.2382 
Cubic -0.0000105 0.4173 
Quadratic Model 
Linear 0.009335 0.2896 
Quadratic -·0.000668 0.0298 
Linear Model 












.. 0.000003 0.9268 
-0.009072 0.4911 
-0.000994 0.1266 
.. 0.016900 0.1048 
----------------------------------------------------------
a adjusted for age, gender, race, smoking, BMI, cholesterol, education 
b adjusted for age, race, smoking, BMI, cholesterol, education 
consistent with the previous analyses using tertiles ofDDE where the relative risk was 
elevated for those in the middle tertile and decreased for those in the highest tertile as 
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compared to the lowest tertile. There was a significant quadratic association (p < 0.05) for the 
total cohort and for men. While the linear trend in the total sample and for the women 
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approached statistical significance (p=0.1 0), the coefficient was negative for both cases and 
hence did not support the hypothesis ofa positive association between DDE levels and cancer 
mortality. 
The graph in Table 34 shows the hazard ratio over the range of DDT levels for the 
quadratic regression model. The mean DDE level for the total cohort was 36.7 ppb, which 
was used as the reference point and the corresponding RR was 1.00. The graph depicts an 
inverted u-shaped relationship between DDE levels and cancer mortality. The maximum 













-36 -30 -23 
Table 34 
Quadratic Regression 
-16 -8.7 -1.7 5.3 12.3 19.3 26.3 33.3 40.3 47.3 54.3 61.3 68.3 75.3 82.3 89.3 96.3 
(DDE-36.7) 
Site Specific Analysis 
Site specific analyses using Cox PH models were conducted for lung, digestive, 
lymphatic and leukemia, and hormone-related cancers. The results of these analyses are 
presented in Table 35. Because of the small number of events, no gender specific analyses 
were performed. 
For lung cancer mortality, there was an apparent increased risk across DDE levels. 
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The RR was 1.3 in both of the two upper tertiles compared to the lowest tertile. However, 
this slight upward trend was not statistically significant. Adding other risk variables 
(education, BMI, race, gender, cholesterol, and smoking) increased the estimates; however, 
the increase was not enough to reach conventional statistical significance and the test for 
trend was not statistically significant (p=0.49). The results for the digestive cancers were 
similar to the results for all cancer mortality. That is, the risk estimate increased in the 
second tertile (RR=2.3; CI: 0.88, 6.2) and then decreased in the third tertile (RR=I.25; CI: 
0.42,3.7). There was no statistical significance observed for either model. The numbers 
were very small in the leukemia and lymphatic groups, 3 cancer deaths in the first tertile, 5 in 
the second tertile, and only 1 in the third tertile. Again, the same pattern was observed where 
the risk estimates increased in the second tertile and then decreased in the third tertile group. 
For hormone-related cancers there was an increased risk ofmortaIity associated with 
increasing levels of DDE. The RR was 1.03 in the second tertile and 1.7 in the third. The test 
for linear trend was not statistically significant (p=0.69) and the confidence intervals for the 
relative risks all included 1.0. Thus no significant association of increased cancer mortality 
for the specified sites and higher levels ofDDE was observed in this cohort for any of the 


















Site Specific Analyses with DDE Tertiles 
Combined Cutpoints 





RRa (95% CI) 
1.00 
1.29 (0.59, 2.83) 
1.31 (0.61, 2.85) 
RRb (95% CI) 
1.00 
1.31 (0.58, 2.94) 
1.65 (0.73,3.75) 





RRa (95% CI) 
1.00 
2.34 (0.88, 6.23) 
1.25 (0.42, 3.74) 









RRa (95% CI) 
1.00 
2.15 (0.51, 9.01) 
0.36 (0.04, 3.48) 
RRb (95% CI) 
1.00 
2.54 (0.53, 12.13) 
0.44 (0.040,4.73) 
Relative Risks for Hormone-Related Cancer Mortality 
cases RR8 (95% CI) RR b (95t}'o CI) 
5 1.00 1.00 
4 1.03 (0.28, 3.84) 0.62 (0.14, 2.68) 
8 1.67 (0.55, 5.11) 1.18 (0.35, 4.02) 
a Cox regression models adjusted for age 
b Adjusted for age, smoking, race, gender, BMI, cholesterol, education 
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Actual versus Reported Use 
The mean serum level ofp,p'DDE of those who reported using pesticides was 
compared to those who reported no use. As noted in Table 36, in all race-gender groups, 
except the high SES black men, there were similar serum DDE values for those reporting 
some previous pesticide use compared to those reporting no previous use. These results 
Table 36 
Reported Pesticide Use* versus Serum ODE Levels 
By Race-Gender Groups 
Mean (± sd) Serum Level ofp'pDDE 
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White White Black Black HSES Black 
Male 
Use 
NO 32.05 (19.42) 







27.16 (19.08) 64.78 (52.66) 
27.91 (16.29) 55.79 (31.80) 
0.73 0.28 








By gender groups 
Female Male 
48.92 (24.23) 31.86 (11.98) 
















*Answered yes to any of the three questions asked in 1974/75 
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suggest that self-reported exposure data was not a very good surrogate for exposure in this 
cohort. F or valid analyses of exposure based on self-report, there should have been a greater 
serum DDE values among those who reported a positive usage of DDT. This was not the 
case. 
Specific Aim 3 
To test the hypothesis that there is increased risk of breast and prostate cancer 
associated with increasing levels of ODE 
Vital Statistics and Cancer History 
Table 37 contains the number of cancer incidence cases occurring dwing the twenty-
year follow-up, 1974-1994. Twenty-one women developed breast cancer, 18 white women 
and 3 black women, while 28 men developed prostate cancer, 17 white men, 7 black men and 
4 high SES black men. These rates were in agreement with the expected number of cancers 
from the national statistics for the same time frame (NCI, 1995). 
Table 37 
Incident Cases of Cancer Validated after 1974/75 
Among Those with DDT-DDE Measurements 
All Cancers Breast Prostate 
White Men 60 0 17 
White Women 54 18 0 
Black Men 21 0 7 
Black Women 12 3 0 
High SES Black Men 11 0 4 
Total 158 21 28 
All 21 women who developed breast cancer and all 28 men who developed prostate cancer 
were selected as cases and matched by age and gender to four cohort members who had not 
developed cancer. These 217 subjects comprise the group analyzed for this specific aim. 
Mean levels of DDE 
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The mean serum levels ofDDE in 1974/75 for those men who developed prostate 
cancer over the twenty-year period compared to their controls was 33.8 vs 41.4 ppb. The 
mean level for women who developed breast cancer over the twenty-year period compared to 
their controls was 26.7 vs 35.1 ppb.. Those who developed breast or prostate cancer 
averaged lower serum levels ofDDE in 1974 than their cancer free controls. The differences 
were statistically significant for both men and women using matched analysis. 
Confounding 
To investigate the potential existence of confounding variables, univariate descriptive 
statistics for selected variables were examined across the exposure levels obtained for those 
with cancer and their controls. Logistic and linear regression models were constructed with 
DDE levels included as an ordinal variable to determine the presence of a linear trend. 
Analysis was done for men and women separately. Table 38 contains the comparison of 
putative risk factors across DDE tertile levels for the men. DDE levels decreased with 
educational attainment, while there was no trend across DDE levels for age, race and 
cholesterol. There was a suggestive association of smoking and higher BMI levels with 
increasing levels ofDDE. The p-value for trend in both variables was only marginally 
significant (p=O.08). 
Table 38 
Comparison of Putative Risk Factors by Serum DDE Tertiles for Men 
Age (mean, years) 
Race (% White) 
Smoking (0/0 yes) 
Cholesterol (mean, mg/dl) 
Education (mean, years) 
BMI (mean, kgIml) 

































Table 39 contains the results of similar analyses for women. Increasing levels of 
97 
DDE with age and higher levels in blacks compared to whites were noted for the women. No 
statistically significant trends were seen for smoking, cholesterol, education or BMI. A 
number of breast cancer risk factors were also examined to detennine any association with 
serum DDE levels in women. A decrease in the percent who reported a positive lactation 
history across increasing DDE tertiles was seen, but this was not statistically significant 
(p=O.41). There was a suggestive trend of the percent reporting a positive family history of 
breast cancer. Th~ trend, however, was in a negative direction, indicating lower DDE levels 
were associated with an increased probability of positive family history for breast cancer. 
Table 39 
Comparison of Putative Risk Factors by Serum DDE Tertiles for Women 
DDE Tertiles 
Age (mean, years) 
Race (0/0 White) 
Smoking (0/0 yes) 
Cholesterol (mean, mgldl) 
Education (mean, years) 
BMI (mean, kg/ml) 
Nulliparous (0/0 yes) 
Lactation (% yes) 
Family history breast cancer (%,yes) 





















































These potential covariates were also tested to determine if they were associated with 
an increased risk for cancer in the CHS cohort. After consideration of the matching criteria, 
several putative risk variables were associated with prostate cancer for the men. As shown 
in Table 40, those men with higher education and who were non-smokers were at a higher 
risk for prostate cancer. No other variables were found to be significant risk factors either in 
the unmatched or the matched analysis. 
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Table 40 
Selected Characteristics of Prostate Cancer Case Patients and Controls 
Variable Cases Controls p-valuea matched 
(0 28) (0=112) p-valueb 
Age at 1974/75 exam 60.3 59.7 0.74 
Race (% white) 60.7 60.7 1.00 
Education (mean, years) 10.6 9.9 0.43 0.05 
BM! (mean, kg/m2) 25.6 26.6 0.33 0.10 
Cholesterol (mean, mg/dl) 270.0 275.7 0.41 0.13 
Smoking (%, current) 32.l 38.4 0.62 0.02 
a p-value derived from pooled t-test or chi-square analysis 
b p-value derived from matched analysis, matched on age and race 
Table 41 shows the results for women and breast cancer. A higher body mass index, 
higher cholesterol level and negative lactation history were found to be risk factors for breast 
cancer in the cohort. There was little difference in the other risk factors between the cases and 
controls. 
In summary, few variables were identified as confounders. Among the men, the only 
variable tb~-tt was significantly associated (at the 0.05 level) with D[JE levels and also a risk 
for prostate cancer was education. Among the women, there were no iaentifiable 
confounding variables. 
Table 41 
Selected Characteristics of Breast Cancer Case Patients and Controls 
Case Control 
Variable (0-21) (n=84) 
Age at 1974/75 exam 57.7 57.9 
Race (% white) 85.7 85.7 
Education (mean, years) 10.6 10.5 
BMI (mean, kg/m2) 27.2 25.3 
Cholesterol (mean, mg/dl) 257.0 242.2 
Smoking (%, current) 19.0 17.8 
Nulliparous (% yes) 19.0 15.5 
Lactation (%) 
yes 28.6 55.9 
no 38.1 17.9 
unknown 33.3 26.2 
History of Breast Cancer (%) 
yes+ 23.8 15.5 
no 66.7 79.7 
unknown 9.5 4.8 
Age at first full tenn pregnancy(%) 
> = age 30 years 4.8 8.3 
< age 30 years 61.9 63.1 
unknown 33.3 28.6 
a p-value derived from pooled t-test or chi-square analysis 
b p-value derived from matched analysis, matched on age and race 
+ history = yes if mother, sister or daughter had breast cancer 














The results presented in Table 42 give the relative risk for prostate cancer incidence 
associated with DDE levels categorized into tertiles. The analysis for the men yielded an OR 
of 1.28 for those in the second tertile compared to the first and an OR of 0.60 for those in the 
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third tertile compared to those in the first. The p-value for trend was not significant, 
indicating no increased risk of prostate cancer associated with increasing levels of DDE. A 
second model which adjusted for other risk variables including education, BMI, cholesterol 
and smoking, showed a slight increase in risk for those in the second tertile. Although, the 
estimates from this model were increased from the first; they still yielded a non-statistically 
significant trend. 
Table 42 
Estimated Relative Risks for Prostate Cancer Incidence 
ODE person-
Tertiles cases years ORa (95% el) ORb (95%CI) 
1 9 728 1.00 1.00 
2 12 685 1.28 (0.49, 3.34) 1.42 (0.52, 3.90) 
3 7 774 0.60 (0.20, 1.78) 0.66 (0.21, 2.04) 
a Conditional logistic regression matched on age and race 
b Matched on age and race; adjusted for smoking, education, BMI, cholesterol 
The results for the relative risk of breast cancer associated with DDE levels in 
women are presented in Table 43. There were 9 breast cancer cases in the lowest level of 
DOE, 7 in the second tertile and 5 in the highest tertile .. Results from the first model 
indicated ::10 significant association between DDE levels and breast cancer incidence. The 
second model, which adjusted for other putative risk factors, showed a further decrease in the 
risk estimates compared to the first model, again indicating no association. Because the 
confidence intervals were wide due to the small sample size and the large set of variables 
included in the model, a stepwise regression was also implemented. This method indicated 
no variables should be included. 
Table 43 
Estimated Relative Risks for Breast Cancer Incidence 
DDE person-
Tertiles cases years ORa (95% CI) ORc (95% CI) 
1 9 706 1.00 1.00 
2 7 618 0.84 (0.27, 2.64) 0.48 (0.02, 9.89) 
3 5 559 0.54 (0.15, 1.96) 0.10 (0.01, 2.40) 
a Conditional logistic regression matched on age and race 
C Matched on age and race; adjusted for smoking, education, BMI, cholesterol, lactation, history, 
nulliparous, and age at first full term pregnancy 
Non-Categorical Analyses of DDE and Cancer 
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The results from the analyses using DDE level as a continuous risk factor for breast 
cancer in women and prostate cancer in men are presented in Table 44. Both of the odds 
ratios were very close to 1 indicating no statistical difference in risk across levels of DDE. 
Since the 95% confidence intervals included 1.0, there was no evidence of a statistically 
significant difference in risk for either breast or prostate cancer associated with increasing 
levels of DDE. Models adjusting for additional covariates made only slight modification in 
the estimates. 
Table 44 
Estimated Relative Risks Matched on Age and Race 








* OR derived from conditional logistic regression 
OR (95% CI)* 
0.975 (0.940, 1.011) 
0.988 (0.969, 1.007) 
Other analyses considered linear, quadratic and cubic terms for DDE levels to 
investigate a possible curvilinear relationship between DDE levels and breast or prostate 
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cancer incidence. These results are shown in Table 45. Polynomial regression models also 
showed no significant association. It was interesting to note that the sign for many of the 
coefficients was negative. This added further evidence in support of the lack of an increased 
risk for higher DOE levels shown in the categorical models. 
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Table 45 
Conditional Logistic Regression Coefficients 
for Association between DDT and Prostate and Breast Cancer 
Men Women 
Coefficient p-value* Coefficient p-value* 
Cubic Model 
Linear 0.001081 0.9567 ·0.013299 0.7359 
Quadratic 0.000524 0.3275 -0.001126 0.3676 
Cubic -0.000009 0.3940 ·0.0000309 0.6333 
Quadratic Model 
Linear ·0.010605 0.4156 -0.029108 0.2252 
Quadratic ·0.0000292 0.8487 -0.001123 0.3142 
Linear Model 
Linear -0.012238 0.2192 ·0.025419 0.1673 
*p-value derived from polynomial conditional regression analyses 
Meta-Analysis/or Breast Cancer 
Because of the existence of a number of published articles regarding the association 
of breast cancer and DDE, a meta-analysis was performed to determine a summary risk 
estimate combining the data from all the investigations. These results found in Table 46 are 
based upon an ext~nsion of an earlier meat-analysis by Adami et. Al (1995). The summary 
ratio was computed as 0.98 (95 % CI = 0.91, 1.06). Thus, all studies considered together 
suggest no increased risk of breast cancer attributable to DDE levels. 
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Table 46 
Summary Analysis of Case-Control Studies for Breast Cancer and DDE 
Using the Mean Ratio as the Effect Measure 
Authorl No. Casesl Case Control Ratio 
Year of study No. Controls Mean Mean (95% el) 
Wassermanl1976 915 1.53 ppm 4.32 ppm 0.35 (0.18-0.70) 
Unger/1984 14/21 1.23 ppm 1.25 ppm 0.98 (0.68-1.43) 
Mussalo-Rauhamaal1990 41/33 0.96 ppm 0.98 ppm 0.98 (0.68-1.42) 
Falckl1992 20120 1877 ng/g 1174 nglg 1.60 (1.09-2.34) 
Wolff/1993 58/171 11.0 nglmL 7.7 nglmL 1 Q 4 3 (1.11-1.84) 
DewaiUy/1994 18/17 1370.6 f.1g1kg 765.3 J.lglkg 1.79 (0.83-3.88) 
Krieger/1994 150/150 43.3 ppb 43.1 ppb 1.01 (0.88-1.14) 
Hunter/1997 236/236 6.01 ppb 6.97 ppb 0.86 (0.74-1.00) 
CHS/1997 21/84 26.7 ppb 35.1 ppb 0.76 (0.57-1.01) 
Summary 0.98 (0.91-1.06) 
v. Discussion 
In 1960, when the Charleston Heart Study (CHS) began, it's primary aim was to 
identify risk factors for heart disease. Data on potential or known risk factors for other 
diseases, including cancer, were not obtained. For example, alcohol consumption and 
diet have been shown to be associated with some cancers (Westview Press, 1982). 
Information pertaining to alcohol use was not collected in the CHS until the mid 1980's 
and studying the relationship of diet and health has not been possible in this cohort. 
While there was one attempt to obtain nutritional information from cohort members, it 
was limited to only a subsample of the cohort at a follow-up examination in 1987/88. 
Other environmental factors including pollution, use of certain consumer products, 
radiation, behavioral and life style factors, as well as infection, have also been suggested 
as risk factors for cancer (Westview press, 1982). These variables were not obtained in 
the CHS and therefore could not be evaluated. Information regarding other suggested 
environmental risk factors for cancer was collected. Tobacco history was collected at the 
baseline examination and also at various follow-up examinations. Education, occupation 
and place of residence for the first 20 years of life, as well as from ages 20-65 was 
obtained at the baseline examination. Physical activity has been inversely linked with 
several types of cancer and self-reported activity levels were collected from CHS 
members in 1963. Limited information on the source of drinking water was also 
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available as participants were asked to simply identify whether or not they used city or 
well water. From the information on these limited environmental factors that were 
available, we observed an increased risk of cancer mortality for men who reported their 
occupation as non-farm laborers. There was also an increased risk of cancer death for 
both men and women with a positive history of cigarette smoking. No other statistically 
significant associations were demonstrated for environmental factors in this cohort. 
In addition to the environmental data collected at baseline, information on 
pesticide use and DDT exposure was obtained in 1974/75. These data represented the 
unique potential to examine the association of DDE levels with cancer in a prospective 
fashion. Serum measurements of ODE were made on 898 participants along with self-
reported use of pesticides in general and DDT in particular. 
Because information was gathered on reported use of pesticides, we were able to 
examine the utility of relying on self-reported data. The serum DDE values which were 
compared with self-reported data and showed a definite discrepancy. It was expected that 
those with higher levels of serum DDE would report more frequent use of pesticides and 
DDT than those with lower levels of DOE. However, this was not the case. The lack of 
agreement between serum levels and DDT use may be explained b:,' the fact that exposure 
occurred through diet in addition to, rather than through, handling pesticides. In this way 
individuals were probably not aware of their exposure. Dependence on self-reported data 
alone was found not to be the best approach for investigating any association with cancer. 
The association of cancer mortality and serum DDT levels in the CHS has been 
examined previously by Austin et al. (1989). The present study added 10 more years of 
follow-up and the number of cancer deaths was doubled compared to that found in 1984. 
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Although some of the statistical methodology was different, overall the results confinned 
the earlier findings that there was no evidence of an increased risk of cancer mortality 
associated with higher DDE levels. 
A number of choices concerning the best statistical approach for examining the 
relationship between DDE and cancer was considered. There did not appear to be a linear 
relationship between the exposure levels and cancer risk. The negative quadratic 
association that was found in the polynomial regression was consistent with the 
categorical analysis using tertiles of DOE. A higher risk for those individuals in the 
middle tertile and a lower risk for those in the upper tertile was observed. These results 
were also confinned using two other approaches. Standardized mortality analysis which 
used an external comparison group, and multivariable analysis which allowed for 
adjustment of other risk factors, were used to describe the relationship between DDE and 
cancer. Both methods confinned the lack of a significant risk of cancer mortality. 
Furthennore, the results from the statistical analyses which were based on external 
comparisons provided evidence that the negative results were not due to any bias 
associated with selection of cohort membership. 
The association of ODE levels with specific cancer mortality was evaluated. The 
sites for these analyses were lung, digestive tract, lymphatic and leukemia, and honnone-
related. Lung, digestive tract, and lymphatic and leukemia have been shown to occur 
with greater frequency among some occupational pesticide users. (See Appendix B). 
Lung cancer was the most frequent cause of cancer death observed within the CHS 
cohort. Although, there was a slight increased risk of lung cancer mortality across ODE 
levels, it was not statistically significant. There were more digestive tract cancer deaths 
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observed in persons in the middle tertile of DDE than in the lowest or highest tertile. 
There were only 9 cases of leukemia and lymphatic cancers, and the analysis indicated no 
increased cancer risk across DDE levels. There were 1 7 hormone-related cancers in the 
CHS. Again, no significant association was found with increasing DDE levels. Because 
of the recent public health interest in DDTIDDE exposure and breast cancer, a specific 
aim was developed to evaluate the relationship ofDDE with incident cases ofhreast and 
prostate cancer. There was no evidence of an increased risk for either breast or prostate 
cancer with higher levels ofDDE. 
Key and Revees had performed a summary ratio of the published case-control 
studies ofhreast cancer using the summary ratios of the mean concentrations of DOE 
between cases and controls (Key & Revees, 1994). They found a summary ratio of 1.11 
(99% CI =0.97-1.26). Adami et aI. performed a similar summary analysis in which they 
included additional data from Wasserman et ale and found the summary ratio to be 1.08 
(95% CI = 0.98 - 1.19) (Adami et aI., 1995). In both of the analyses there was no 
significant association between DOE and breast cancer. . 
The meta-analysis was repeated including the recently published data from the 
Nurses' He:llth Study and those from the CHS cohort (Hunter et aI., 1997). The summary 
ratio was 0.98 (95 % CI = 0.91, 1.06). This summary ratio decreased v/hen the additional 
studies were included, reflecting the negative findings in both of the most recent 
investigations. 
The lack of positive findings was not surprising since the isomers of DDT with 
estrogenic properties are very weak (Stone, 1994). The predominate metabolite, 
p,p'DDE, is not estrogenic, hut has shown antiandrogenic activity in rats (Kelce, 1995). 
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The o,p' isomer of DDT has been shown to be estrogenic in animal studies but is usually 
below the detection limit in human samples (Safe, 1995). 
Limitations 
As noted earlier, we were unable to address many of the suggested cancer risk 
factors such as alcohol consumption and diet. We were, however, able to examine 
information on a number of the other putative risk factors which were collected years 
before the onset of cancer. Although a significant association was observed for men who 
reported their occupation as a laborer, detailed information onjob histories were not 
available. Thus, the contribution of risk of occupation to cancer mortality was limited to 
descriptive studies. 
The results for many analyses were based on relatively small sample sizes. 
However, with a sample of almost 900 there was over 80% power to detect a relative risk 
of 1.40 or greater in the overall cancer mortality analysis (Hintze, 1996). Although small 
effect sizes may not have been detectable, especially in reference to breast and prostate 
cancer, there was sufficient power ( > 80 %) to detect the size of the risk reported by 
others for breast cancer (Wolff, et aI., 1993). Because of the small sampl.;: size we were 
unable to evaluate the relationship ofDDE with all site-specific cancers. Also because of 
the small sample size we were not able to perform separate analysis for ethnic groups; 
however, we were able to adjust for race in all of the analyses. 
There may have been confounders for which we were unable to control, but for a 
variable to be a confounder it must be associated with DDE levels and also be a risk 
factor for cancer. After examining several variables that may have been confounders, age 
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and gender were the only variables identified. After adjustment for these, as well as other 
putative risk factors, there was no evidence of an increased risk of cancer associated with 
the exposure to DDE. The relationship ofDDE levels to incident cases may be different 
than to mortality, but our results on breast and prostate cancer incidence also suggested 
no increased risk. 
Strengths 
This study has several strengths. The cohort had complete follow-up from 1974 
through 1994, and ascertainment and classification of cause of death was done without 
knowledge of the subjects' risk variables. The potential for recall bias was greatly 
reduced, as was selection bias, given the prospective nature of the study. Because of the 
excellent follow-up of our cohort, and the repeated examinations of this group, it is 
unlikely that any cases of cancer were missed. Eighty-six percent of all the reported 
cancers and 100% of the breast and prostate cancers were verified by pathology reports so 
that misclassification errors were minimized. 
The results were obtained from a prospective study in which serum samples of 
DDE were Inade years before the cancer death or incidence, unlike previous studies that 
have determined the serum level at the same time as the cancer diagnosis. The CHS was 
not an occupationally exposed group; however, compared to a national survey, the cohort 
had high levels of DDE. The median DOE level for the CHS was 31 ppb - a value much 




Although the number of subjects available was relatively small, the primary 
strength of the study lies in the extended follow-up time that occurred after the exposure 
assessment data was collected. Given the fairly long latency period associated with 
cancer, sufficient time for follow-up of incidence and mortality is an important 
consideration. The evidence from this prospective study thus makes a substantial 
contribution to the literature related to DDT exposure and cancer. The findings of this 
study suggest there is no increased risk of cancer mortality associated with increasing 
levels ofDDE. For the women, there was no evidence of an increased risk of breast 
cancer incidence; for the men there was no evidence of an increased risk of prostate 
cancer incidence; and for all subjects there was no increased risk of cancer mortality. 
Appendix A 






Benzoyl chloride manufacturers 
Brewery workers 
Calcium Carbide manufacturers 
Cement workers 































Appendix A, continued 
Occupational Group 
Coke by-product plant workers 
Dry cleaning and solvent-exposed workers 
Firefighters 
Glass manufacturers 




Nonionizing Radiation-exposed workers 





































Pulp and paper workers 






























* Monson R.R. "Occupation." Cancer Epidemiology and Prevention, 2nd edition, edited by 
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D. Schottenfeld and J.F. Fraumeni. New York, Oxford Press University. 1996, pp. 418-436. 
Appendix B 
Summary of Studies Regarding DDT and Cancer 
First Authorl Study Design Population Exposure/ 
Year of Type or Source 
Publication 
Adami/1995 Meta Analysis Summary study DDT, PCB, TCDD 
regarding the studies 
published to date on 
breast & endometrial 
cancer and DDT 
AiavanjaJ1990 Occupational Study US Grain Millers Chemicals used in 
Cohort mortality & (1955-1985) facility 
nested case-control 22,938 white males Interviews 
study 
AlavanjaJ1987 Occupational Study Swedish Grain millers Exposure to pesticides 
Prospective cohort (1961-1979) 
2,649 white males 
Alavanjal1987 Occupational Study US Grain millers exposure to pesticides 
Proportionate (1968-1983) 
Mortality 1,114 white males 
Darthcll1987 Occupational Study German pesticide Fungicides, 
Proportionate sprayers insecticides (DDT), 
mortality (1948-78) herbicides, others 
Retrospective 1,658 male 
cohort 
Blair/1979 Case control study Nebraska (1957-74) A death certificate 
white males study 
1,084 cases 2,168 
controls 




Cohort analyzed all 
cause death w/site 
specific cancer 
all cancer and site 
specific 
all cancer and site 
specific 





No association for either 
cancer 
Excess risk for NHL, I 
leukemia and pancreatic 
cancer.; also increase risk 
for case-control study 
Increased risk for liver 
I 
cancer I 
SIR = 238 
Increased risk for 
pancreatic (PMR 191) and 
lymphoma (PMR 272) 





Blair/1983 Occupational Study Florida pesticide 
Retrospective applicators 
cohort ( 1965-1977) 
.. ~. 3,827 white male 
Blair/1991 Occupational Farmers 
Meta Analysis Over 20 cohort studies 




Bouwmanl1994 Malaria control South Africa men and 
Longitudinal women 
prospective cohort 1986-1987 
Bouwmanl1991 Occupational DDT appliers South 
Cross-sectional Africa 
Malaria control 
Black nlcn and \VOlllen 
23 sprayers & matched -
Uro \\/1111990 Population Iowa or Minnesota; 
case-control white men 
(1981=84) 
578 leukemia & 1245 
matched 
Pesticides used in all cancers and site 
structural pest control specific 
(included DDT) 
Pesticides all causes, cancers 
and site specific 
Farmers all cancers and site 
specific 
DDT; blood samples none 
DDT;blood samples none 
Large agricultural leukemia 
populations; risks 
were calculated for 
mix, handling 
insecticides (DDT) 
Overall SMR not 
significant; excess for 
leukemia and brain and 
lung 




myeloma and lip, stomach 
skin prostate brain testis 
and connective tissue 
elevated rates for 





no additional risk from 
1986 to 1987 
DDT levels higher cases 
OR=I.2 for fanners 
compared to non; Slight 








Brownsonl1988 Occupational risk White male (1984-1986) 
cancer registry 1239 prostate cancer 
based case-control matched 3717 controls 
Brownsonl1993 Occupational risk Missouri white women 
Population based (1986-1991 ) 
case-control lung cancer 
Burmeister/1981 Occupational study Iowa farmers 
Proportional (1971-78) 
mortality 6,402 white males 
Burmeister/1982 Occupational study Farmers Iowa 
Case-control study (1964-78) white males 
1,675 cases 3,350 
controls 
Burmeister/] 983 Occupational study Farmers Iowa 
Case-control study (1964-78) white males 
8,290 cancer cases 
Burgazl1995 Population exposed Iran 1991-1992 
Cross Sectional 8 men & 53 female 
Cantor/1984 Occupational study Wisconsin farmers 
Case-control study (1968-76) white males 
411 cases 725 controls 
Cantor/1991 Occupational study US Pesticide applicators 
-- Mortality cohort (1965-1979) 
9,727 white male 
Cantor/1992 Occupational risk Agricultural workers in 
Population based Iowa and Minnesota 
case control (1980-83) 
white males 
622 NHL & 1245 
matched 




Interviews obtained lung cancer 
occupational factors 
Pesticides, herbicide all cancers and site 
specific 
Pesticides, herbicides leukemia 
Pesticides, herbicides all cancers and site 
specfic 
DDT, DDE; adipose none 
tissue 
A death certificate multiple myeloma 
study 
Pesticides, herbicides 
Pesticides all causes, cancers 
and site specific 
Pesticides; Interviews NHL 
Increased risk of prostate 
cancer among fanners 
elevated risk among 
women exposed to 
asbestos and pesticides 
elevated stomach, skin, 
prostate, lip, colon, 
pancreas, leukemia 
OR=I.24 signficantly 
increased risk of leukemias 
for farmers 
elevated muliple myeloma, 
nonHodgkins lymphoma, 
stomach, prostate 
DDEIDDT increased from 
1.91 to 11.82 
OR=I.4; signficant 
increase risk of myeloma 
for farmers 
SMR below expectation 





CarlsonJ1978 Occupational study California agricultural 
Proportional workers 
Mortality cohort (1959-1961) 
3,844 white males -
Coggonl1986 Occupational study British pesticide sprayers 
Proportionate (1947-75) 
mortality 9,677 white males 
cohort 
Curtis/1994 Descriptive study Should DDT continue to 
Meta-Analysis be used for malaria 
control? 
Davis/1992 Occupational Farmers 
Meta-Analysis 20 studies in 8 countries 
Delzell/1985 Occupational study NC farmers 
Proportionate (1976-1978) 
mortality white and nonwhite 
De Wailly/1994 Population Women (1991-1992) 
Hospital case- 20 breast cancer & 17 
control match 
Dosemeci/1994 Exploratory NC black southeastern 
occupationa' study states 
using de"'i i· ~,.'.L\l 
certificates 
Erikssonl1992 Occupational risk Sweden (1982 ... 1986) 
Population based 239 myeloma & 
case control matched control 
~-... ,--
Farm laborers and all causes, cancer 
foremen compared to and site specific 
farm managers 
MCP A and other all cancer and site 
pesticides specific 
DDT pancreatic and 
breast 
21 broad occupational cancer and site-
surveys specific 
Farming listed as all; cancer and site 
occupation of death specific 
certificate 
PCB, DDE; fat and breast cancer 
plasma 
prostate cancer 
Questionnaire Multiple myleoma 
regarding occupations 




Meta anlaysis for these 
cancers 
Increased sites: melanoma, 
prostate, NHL, multiple 
myeloma, breast, brain, 
kidney 
PMR = 90 whites 
significant; 
PMR = 90 nonwhite ns 
Both increased prostate 
Women ER+ breast cancer 
had higher levels DDE 
3 8%of excess prostate 
cancer mortality may be 
associated with farming 
Association found among 




Falckl1992 Population Women white (1987) 
Hospital case- 20 breast cancer&20 
control benign 
Fasal/1968 Occupational study Farmers in California 
Proportionate (1959-1961) 
mortality 1,857 white males 
Frank/1988 Population Ontario Residents, 1976-
Cross Sectional 1985 
570 adipose sample; 348 
milk; 118 blood 




Garabrantl1992 Occupational risk Chemical manufacturing 
nested case-control workers (1948-1971) 
white & non white males 
28 pancreatic & 112 
matched 
Garry/1994 Occupational study Minnesota pesticide 
cross-sectional appliers 
survey 719 random selected 
proportionate males 
mortality 
Hansen/1992 Occupational study Danish gardeners 
Prospective cohort (1975-1984) 
4,015 males and females 


































cancer and site 
specific 
sinonasal cancer 
Elevated levels DDT in fat 
women with breast cancer 
nonsignficant elevated 
ratios 
DDT declined 1970s to 
1980s 
PMR 78 ns for all cancers 
stomach cancer increased 
OR=4.8 
Chronic disease increased 
in fumigant appliers 
males significant increase 
soft tissue sarcoma, 






Hooly/1992 Parental Occupation Mothers 43 Ewing's Interview on Ewing's bone elevated risk for children 
risk bone sarcoma patients occupational hx sarcoma whose fathers exposed to 
case control study (1978-1986) & 193 herbicides, pesticides or 
controls in CA fertilizers -_ ....... _. 
Hovinga/1993 Environmental Great Lake fisheaters Lead, Cadmium, PCB, none Elevated PCB and DDT 
exposed (1982-1989) and DDT; blood levels observed for fish 
Prospective cohort male and female white samples eaters 
115 fish and 95 nonfish 
eaters 
Kashyap/1993 population exposed India DDT and HCH; fat none males had higher residues 
cross-sectional male and female and blood samples than females 
21 fat tissue & 20 blood 
Kashyap/1994 population exposed India food intake DDT and BCR; food none Blood DDT levels 
Cross Sectional male and female and blood samples reflected food intake 
20 duplicate diet 
samples 
Keil/1973 Population GAand SC DDT; blood none blacks higher DDT then 
black and white whites 
Key/1994 Meta-Analysis 6 studies regarding DDT DDT,DDE,PCB; breast cancer Summary DDE 1.11 
and breast cancer blood, fat (99%CI: 0.97-1.26) 
Kreiger/1994 Population N.CA Region Kaiser DDE,PCB; blood breast cancer no association; there is an 
Nested case-control Permanente Medical association for white and 
Incidence Care Prgm black 
white,black,asian 
women 




Kreiss/1981 Population exposed Triana,AL downstream 
cross-sectional defunct DDT plant in 
1979 
males and females adults 
and children 
Littorinl1993 Occupational study Swedish market 
Retrospective gardeners 
cohort (1965 .. 1982) 
Mortality and 2370 horticulturists' 
morbidity association 
Lopez- Populational study Public health impact in 
Carrillo/1996 Descriptive and Mexico during the last 
summary study 20 years 
Ludwicki/1994 Population Poland 1989-1992 
Cross Sectional 277 men and women 
age 10 - 80 
Mabuchi/1980 Occupational study Pesticide Manufacturing 




Morrisonl1992 Occupational study Canadian prairie farmers 
Mortality cohort (1971-1987) 
156,242 male farmers 
Morrisonl1995 Occupational study Canadian farmers 
Retrospecti ve (1971-1987) 
mortality cohort 145,383 male over 45 
yrs 
DDT;blood none 
Fungicides and all cancers 
Insecticides 
DDT and DDE none; Analysis of 
studies with levels 
in blood, fat and 
milk 
DDT, DDE, HCH, none 
HCB, PCB; adipose 
tissue 
DDT, chlordecone, all cancers and site 
Aldrin, arsenate, specific 
organophosphates, 
herbicides 
Exposure indices from all and brain 
1971 Census cancer 
Agricultural records 
Herbicides, prostate cancer 
insecticides, 
fertilizers, other 
DDE accounted for an avg 
of 86.7% of total DDT 
SMR = 90 ns for all 
cancers 
Compares levels in Mexico 
and the US 
DDE highest 
concentration; age factor 
lung 
SMR = 77 ns for all cancer 
Association between 
number of acres sprayed 
with herbicides and risk of 




Moysichl1997 Populational study postmenopausal women 
case-control study 154 cases; 192 controls 
Murphy/1985 Population Survey NHANES II, 12-74 yrs 
Cross Sectional from 64 locations across 
US 
Mussalo- Population Finland (1985-1986) 
Rauhammal1990 Hospital case- women 
control 44 breast & 33 controls 
Pesatori/1994 Occupational study Florida pesticide appliers 
Prospective cohort (1965-1982) 
& 4,441 white and black; 
nested case-control male and female 
Pines/1987 Population 1975 and 1985 blood 
Longitudinal Study 
Polandl1970 Occupational study DDT Factory workers 
Rappoltl1970 Occupational risk Kern County, CA 
Cross Sectional male and female; white, 
black, Spanish; autopsy 
material 
Riihimaki/1982 Occupational study Finnish sprayers 
Mortality study (1955-71) 
1,926 Finnish men 
Rivero- Occupatinal study Spraying DDT to control 
Rodriguezl1997 Cross sectional malaria in Mexico 
study 371 sprayers with over 
20 years on the job 
- -- --
Serum levels of DOE breast cancer 
DDT, DDE; blood none 
DDT,DDE,HCH,DD breast cancer 
D,PCB,HCB; adipose 
tissue 




DDT, ODE, DDD none 
DDT; serum and none 
adipose tissue 
Pesticide input is the none 
third highest per area 
in the world; 
fat, placenta, cords 
Dichlorophenoxy all cancers 
acetic acid, herbicid;'~ 
DDT and DDE none; measured 
mean levels in 
adipose tissue and 
J?y questionnaire 
OR=1.49(O.73,3.04) 
No association DDE and 
postmenopausal breast 
cancer 
Median DDE level 18.3 
ppb 
no association 
SMR = 140 all cancers; 
OR 2.1 for lung cancer 
licensed over 20 years 
Lower levels in 1975 than 
in 1985 I 
DDT levels 20 to 30 times I 
higher in cases- . 
no difference between farm 





High levels found; derived I 








Rogan/1987 Population Mothers North Carolia Breast 
Prospective birth Milk & Formula Project 
cohort enrolled 1978-82; 858 
children from birth to 
lyr 
Ronco/1992 Occupational study Danish and Italian 
Prospective cohort Farmers 
1970-1980 
Males and females; 15-
75 yrs old from cancer 
registry 
Saftlas/1987 Occupational study Wisconsin farmers 
Mortality study (1968-76) 
35,972 white males 
Shindell/1986 Occupational study Chlordane factory 
Prospective workers 
mortality ( 1946-1985) 
800 white,black, 
male,female 
Spicer/1993 Population Mothers New Guinea Lactating 
Cross Sectional mothers 1990 
Stevens/1993 Population Mothers Australian Nursing 
Cohort Study mothers 
white women 
Sturgeonl1997 Populational study women 
PopuhHh;U case- (1987-1990) 
control 97 cases 97 controls 
Stubbs/1984 Occupational study California agricultural 
Mortality study workers (1978-79) 
- ----- . -~~- '-----
7,504 white/non males 
DDT, DDE; blood, none 
cord, placenta, milk 
Occupational census all cancers and site 
data specific 
pesticides all cancers, site 
specific 
chlorodane all cancers 
DDT; milk none 
DDT, HCB, Dieldrin none 
measured serum DDE endometrial cancer 
levels; large 
multicenter trail 
pesticides all cancers, site 
specific 
High levels ofDDE 
associated with shorter 
lactation 
Reduced risk of lung, 
bladder, small intestine, 
colon, rectum and prostate 
stomach, prostate, 
leukemia, eye, lymphoma 
SMR87 
100% of mothers had DDT 
in their milk 
A fall in level of Ocs was 
noted since 1974 survey 
Quartne~ 1.0, 0.85, 1.1, 1.1 
no association DDE and 
endometrial cancer 








Unger/1982 Populational study 51 cancer cases from 
Case-control study autopsy and controls 
Unger/1984 Population Women : cases 14 breast 
Hospital case- patient, 18 breast 
control deceased; 
controls 21 noncancer 
patient, 35 noncancer 
deceased 
Van der Occupational Case-control studies, 
Gludenl1996 Meta Analysis cohort studies & death 
certificate 
Wangl1979 Occupational study Nationwide pesticide 
Prospective cohort appliers 
(1967-1976) 
16,126 white males 
Wassermann! population women; Camargo 
1976 Hospital case- Hospital 
control 9 breast and 5 controls 
Mortality Autopsy material 
Westonl1990 Population Women in Israeli 1976-
Correlationa1 ~tHdy 1986 
Mortality 
DDT and PCB; All cancers 
adipose 
DDT, PCB; adipose breast cancer 
tissue 
Farmers prostate 






DDT; malignant and breast cancer 
adjacent adipose 
tissue 
Pesticide residues in breast cancer 
cows; DDE,Lindane, 
BHC 
Correlation found between 
cancer and DDT in fat 
no association 
excess risk of prostate 
cancer 
SMR 83 all cancer ns 
Bladder cancer was in 
excess 
increase in DDT compared 
to adjacent tissue 
breast cancer mortality rate 
double than other countries 







Wigle/1990 Occupational Study Canadian farm operators 
Mortality cohort (1971-1985) 
70,000 male farmers 
Wiklund/1989 Occupational study Swedish pesticide 
Prospective cohort appliers 
(1965-1982) 
20,245 male and female 
Wiklund/1986 Occupational study Swedish agricultural 
Retrospective workers 
cohort (1961-1979) 
254,417 men cancer 
registry 
Wolff/1993 Population Women NY University 
Case-control/cross Health Study (1985-
sectional 1991) 
58 breast & 171 match 
Wongl1984 Occupational study Chemical workers 
Historical manufacturing plants 
prospective (1935-1976) 
mortality study 3,579 US white men 
Zahml1992 Occupational 21 farm studies 
Meta Analy_sis 
Zahml1993 Occupational Farmworkers in US and 
.. 
Meta Analysis Canada 
-_ ... __ ._------_ .• - -- -
1971 Census of all causes; all 
agriculture; cancers and NHL 
Herbicides and 
insecticides 
Pesticides all cancers 
Cancer Environment all cancers and site 
Registry specific 
DOE, PCB; blood breast cancer 
DDT, DBCP, TRIS, all cancer and lung 
PBB cancer 
pesticides NHLonly 
pesticides all cancers and site 
specific 
._-
no excess risk 
significant decreased risk 
RR=0.82 
4 fold increase risk of 
breast cancer for high 
levels of ODE 
SMR 95 ns all cancer for 
specific DDT e~posure 
listed 
excess NHL 
Describes a few studies 











SMR of Cancer Deaths for Charleston Heart Study 
by Age and Calendar Year 
Age Calendar Year 
1974n5 
1974-79 1980-84 1985-1989 1990-1994 TOTAL 
35-44 obs death 0 0 0 0 0 
person years 53.96 0 0 0 53.96 
N 9 0 0 0 
rate* 100,000 ° 0 0 0 0 expected 0.031 0 0 0 0.031 
SMR 0 
45-54 obs death 4 0 0 ° 4 person years 1622.20 169.08 44.97 4.97 1841.22 
N 278 34 9 1 
rate * 100,000 246.58 0 0 0 246.58 
expected 2.91 0.30 0.07 0.007 3.287 
SMR 1.22 
55-64 obs death 7 4 4 2 17 
person years 2023.33 1712.38 1191.86 265.85 5193.42 
N 350 354 248 55 
rate* 100,000 345.96 233.59 335.61 752.301 327.34 
expected 8.69 7.57 5.39 1.17 22.82 
SMR 0.74 
65 ... 74 obs death 15 14 18 8 55 
person years 1201.19 1320.02 1280.15 1441.94 5243.30 
N 216 288 281 304 
rate* 100,000 1248.76 1060.59 1456.08 554.808 1048.95 
expected 9.40 10.91 10.96 12.6 43.87 
SMR 1.25 
75-84 obs death 4 5 4 15 28 
f'ers.on years 233.53 435.25 591.66 721.07 1981.51 
N 43 99 135 178 
·t~e* :t 00,000 1712.84 1148,76 676.07 2080.24 1413.09 
e;{rected 2.90 5.41 7.65 9.79 25.75 
SMR 1.09 
>85 obs death 0 ° ° 4 4 person years 11.99 71.81 77.93 136.94 298.73 
N 2 18 25 41 
rate* 100,000 ° ° ° 2920.90 1338.98 expected 0.19 1.15 1.29 2.44 5.07 
SMR 0.19 
TOTAL obs death 30 23 26 29 108 
person years 5146.20 3708.60 3186.57 2570.76 14612.13 
N 898 793 698 579 
rate* 100,000 582.95 620.18 851.92 1128.07 739.11 
expected 24.21 25.34 25.36 26.01 100.83 
SMR 1.24 0.91 1.02 1.11 1.01 
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AppendixD 
SMR for Cancer Death Rate by DDE Tertiles, Calendar year and Age 
Stratum DDE Tertile 
Year, Age 1 2 3 TOTAL 
1974-1979 
35-44 observed 0 0 0 0 
person-year 11.99 11.99 29.98 53.96 
expected 0.007 0.007 0.017 0.031 
SMR 0 
45-54 observed 3 0 1 4 
person-year 629.05 538.26 454.88 1622.19 
expected 1.13 0.967 0.817 2.91 
SMR 1.37 
55-64 observed 2 1 4 7 
person-year 681.766 695.11 646.45 2023.33 
expected 2.93 2.98 2.77 8.68 
SMR 0.81 
65-74 observed 3 6 6 15 
person-year 402.809 381.582 416.80 1201.19 
expected 3.15 2.98 3.26 9.44 
SMR 1.59 
75-84 observed 1 1 2 4 
person-year 78.398 53.79 101.34 233.53 
expected 0.97 0.67 1.26 2.9 
SMR 1.38 
>84 observed 0 0 0 0 
person-year 5.99 0 5.99 11.98 
expected 0.096 0 0.096 0.19 
SMR 0 
Total observed 9 8 13 
person-year 1810.0 1680.7 1655.44 
expected 8.28 7.60 8.22 
SMR 1.09 1.05 1.58 
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Stratum DDE Tertile 
Year, Age 1 2 3 TOTAL 
1980-84 
35-44 observed 0 0 0 0 
person-year 0 0 0 0 
expected 0 0 0 0 
SMR 0 
45-54 observed 0 0 0 0 
person·year 29.99 59.99 79.09 169.07 
expected 0.05 0.11 0.14 0.30 
SMR 0 
55-64 observed 2 2 0 4 
person-year 721.25 550.57 440.55 1712.37 
expected 3.19 2.43 1.95 7.57 
SMR 0.52 
65-74 observed 1 8 5 14 
person-year 425.63 410.14 484.25 1320.02 
expected 3.52 3.39 4.00 10.91 
SMR 1.28 
75-84 observed 5 5 1 11 
person-year 152.55 146.68 136.02 435.25 
expected 1.89 1.82 1.69 5.4 
SMR 2.04 
>84 observed 0 0 0 0 
person-year 31.573 15.0 25.29 71.86 
expected 0.506 0.24 0.405 1.15 
SMR 0 
Total observed 8 15 6 
person-year 
expected 9.16 7.99 8.18 
SMR 0.87 1.88 0.73 
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Stratum DDE Tertile 
Year, Age 1 2 3 TOTAL 
1984-1989 
35-44 observed 0 0 0 0 
person-year 0 0 0 0 
expected 0 0 0 0 
SMR 0 
45-54 observed 0 0 0 0 
person-year 9.99 9.99 24.98 44.96 
expected 0.016 0.016 0.04 0.07 
SMR 0 
55-64 observed 0 1 3 4 
person-year 482.45 391.06 318.34 1191.85 
expected 2.18 1.77 1.44 5.39 
SMR 0.74 
65-74 observed 6 8 4 18 
person-year 474.015 397.80 408.934 1280.75 
expected 4.06 3.41 3.5 10.97 
SMR 1.64 
75-84 observed 2 2 0 4 
person-year 215.206 149.645 226.806 591.66 
expected 2.78 1.93 2.93 7.64 
SMR 0.52 
>84 observed 0 0 0 0 
person-year 33.601 21.26 23.07 77.93 
expected 0.56 0.35 0.38 1.29 
SMR 0 
Total observed 8 11 7 
person-year 
expected 9.74 7.48 8.29 
SMR 0.82 1.47 0.84 
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Stratum DDE Tertile 
Year, Age 1 2 3 TOTAL 
1990-1994 
35-44 observed 0 0 0 0 
person-year 0 0 0 0 
expected 0 0 0 0 
SMR 0 
45-54 observed 0 0 0 0 
person-year 5.0 0 0 5.0 
expected 0.007 0 0 0.007 
SMR 0 
55-64 observed 0 0 2 2 
person-year 79.94 104.93 80.98 265.85 
expected 0.351 0.46 0.355 1.17 
SMR 1.71 
65-74 observed 3 4 1 8 
person-year 602.53 463.66 375.74 1441.93 
expected 5.26 4.05 3.28 12.59 
SMR 0.63 
75-84 observed 7 4 4 15 
person-year 232.526 180.843 307.658 721.03 
expected 3.16 2.45 4.17 9.78 
SMR 1.53 
>84 observed 3 1 0 4 
person-year 69.476 31.19 36.27 136.936 
expected 1.15 0.56 0.65 2.45 
SMR 1.63 
Total observed 13 9 7 
person-year 
expected 9.93 7.52 8.45 
SMR 1.31 1.20 0.83 
Overall 
TOTAL observed 34 41 33 108 
person-year 5375.73 4613.49 4623.415 14612.64 
expected 36.963 30.64 33.15 100.75 
SMR 0.936 1.34 0.997 1.07 
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